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1 Summary 
A fundamental reprogramming occurs during the oocyte-to-embryo transition (OET) of an animal, from a 
transcriptionally silent, differentiated oocyte to a pluripotent early embryo. The two major events 
contributing to the cell fate change are maternal transcript degradation and embryonic genome activation 
(EGA). We used Caenorhabditis elegans as a model to study the mechanisms controlling EGA during this 
developmental window and performed a genetic screen for the unbiased identification of new involved 
players. We discovered several factors inhibiting a precocious onset of EGA in germ cells, among them 
several components of the CSR-1 endogenous-small interfering RNA (endo-siRNA) pathway. This pathway 
employs the Argonaute protein CSR-1 to load small RNAs and has been implicated in diverse processes in 
germ cells and early embryos. Here, we demonstrate a role for this pathway in the repression of 
embryonic genes in developing oocytes. Moreover, we found that the catalytic activity of CSR-1 to 
degrade RNAs is required for this function. The importance of such a post-transcriptional role is in 
accordance with previous findings, which described a function for the RNA-binding proteins GLD-1 and 
LIN-41 in germ cell fate control. Our discovery of a direct interaction of CSR-1 and LIN-41 suggests a co-
regulatory role for the two proteins in EGA repression. Together, the results contribute to the 
understanding of the reprogramming during the C. elegans OET and highlight for the first time the 
importance of endo-siRNAs in this process.  
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2 Introduction 
2.1 Cell fate maintenance and reprogramming during the oocyte-to-
embryo transition 
This chapter is adapted from the book chapter of the same name, published in: 
Signaling-Mediated Control of Cell Division 
 From Oogenesis to Oocyte-to-Embryo Development  
© Springer, 2017  
Authors: Christina Fassnacht and Rafal Ciosk 
 
2.1.1 The oocyte-to-embryo transition 
Cellular differentiation leads to the formation of highly specialized cells, such as neurons and muscles, 
which fulfill complex functions. Cellular reprogramming is the opposite process, where a specialized cell, 
with a restricted developmental potential, is turned into a pluripotent cell that can give rise to different 
types of cells. During development, a complete reprogramming into pluripotency is restricted to the 
oocyte-to-embryo transition (OET). During this transition, a fertilized oocyte develops into a pluripotent 
embryo, which has the potential to give rise to an entire new individual. The main cellular processes 
occurring during the OET are oocyte maturation, ovulation, and fertilization. Those processes will be 
described in more detail for the model Caenorhabditis elegans in chapter 2.2. In this chapter, we focus on 
the changes in the transcriptome, underlying the transition from maternal to embryonic control of 
development. In addition, we concentrate on mechanisms operating in the oocytes, because unfertilized 
oocytes display a broad developmental potential, which is evident by their ability to give rise to 
developmentally plastic parthenogenetic cell lines (Brevini et al. 2012), or even offspring when paternal 
imprinting is mimicked (Kono et al. 2004). The initial stages of the OET, from oocyte maturation to early 
embryogenesis, occur in the absence of de novo Pol II-mediated transcription and are controlled, post-
transcriptionally, until the embryo begins producing its own transcripts during EGA (LaMarca et al. 1975; 
Moore et al. 1974). Our current understanding of the mechanisms controlling developmental 
reprogramming during the OET remains very limited. Experiments with pluripotent embryonic stem (ES) 
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cells have shown that pluripotency can be regulated at each step of gene expression. However, which of 
the mechanisms described in ES cells are employed during development remains to be, to a large extent, 
determined. During development, a successful OET depends on the ability to maintain the germ cell fate 
in a developing oocyte, which includes the maintenance of germ line-specific gene expression and the 
inhibition of soma/embryo-specific expression. Failures in this process can result in a precocious 
acquisition of pluripotency and somatic-like, teratomatous differentiation. In an early embryo, the 
regulation of gene expression is reversed, resulting in the activation of somatic/embryonic genes and the 
inhibition of germline genes. In this chapter, we will discuss critical factors and emerging mechanisms 
controlling this dramatic reprograming of gene expression.  
2.1.2 Developmental potential of germ cells 
Germ cells are typically the only cells giving rise to the offspring. This striking property of germ cells led to 
the formulation of the germ-plasm theory of heredity, also known as the Weismann theory of heredity, 
which states that only germ cells transmit genetic information to the next generation (Weismann 1893). 
Indeed, the development and maintenance of germ cells is crucial for the survival of species with sexual 
reproduction and germ cell-specific genome surveillance mechanisms have evolved to ensure genome 
integrity. Germ cells originate from primordial germ cells (PGCs) that are usually specified during 
embryonic development, for a recent review on the specification of germ cell fate in different organisms 
see (Strome and Updike 2015). PGCs and also adult germ cells have the potential to give rise to other 
types of cells, as evident by the different types of pluripotent cell lines derived from germ cells at different 
stages of development (Kerr et al. 2006). For example, embryonic germ (EG) cells can be derived from 
mouse PGCs between the embryonic days E8.5 until E13.5 (Cantone and Fisher 2013). The EG cells are in 
many aspects like blastocyst-derived embryonic stem (ES) cells, in that they can generate chimeras and 
display germline transmission (Smith 2001). The pluripotency of germ cells is also manifested by the 
properties of a specific germ cell tumor (GCT) called teratoma. In human teratomas, germ cells abnormally 
differentiate into somatic cell types, such as neurons, muscles, hair or teeth (Ulbright 2005). They can 
arise in ovary and testis, with testicular GCTs accounting for the most common solid malignancy found in 
males between the ages of 15 and 40 years (Hussain et al. 2008). Origins of GCT development during 
human and mouse gametogenesis have been recently reviewed in (Dolci et al. 2015). They include 
epigenetic remodeling, as well as defects in proliferation, apoptosis and the mitotic to meiotic switch. 
Undifferentiated cells from teratomas can also be grown ex vivo as embryonic carcinoma (EC) cells and 
can be differentiated into cells of all three germ layers in culture (Smith 2001). The formation of teratomas 
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shows that, to ensure normal development, there need to be repressive mechanisms operating in adult 
germ cells to control pluripotency. It is mostly the work from the nematode C. elegans that contributed 
to the identification of pluripotency repressors, which will be discussed later. A final evidence for the 
underlying pluripotency of germ cells is the ability of the oocyte cytoplasm to reprogram somatic nuclei. 
This was experimentally demonstrated, by using the cytoplasm of an enucleated Xenopus oocyte to 
reprogram an intestine nucleus (Gurdon and Uehlinger 1966). Since then, reprogramming has been mostly 
studied using cell culture. This revealed some important regulators, most notably the pluripotency 
transcription factors Oct4, Sox2, Klf4 and c-Myc (Takahashi and Yamanaka 2006). However, the 
reprogramming remains a very inefficient process, indicating that repressive mechanisms stabilizing the 
differentiated state may exist (Pasque et al. 2011). Arguably, understanding the mechanisms controlling 
the natural reprogramming during OET may be useful for improving the in vitro reprogramming 
techniques. 
2.1.3 Control of embryonic genome activation  
Two major processes occur during the OET to reprogram the transcriptome. One is the maternal 
clearance, the degradation of many maternal mRNAs and proteins deposited into the oocyte. The 
mechanisms behind the maternal clearance have been recently reviewed (Barckmann and Simonelig 
2013; Walser and Lipshitz 2011). The other process is the embryonic genome activation (EGA), the onset 
of transcription in the early embryo. In the following, we concentrate on the advances that have been 
made in understanding the timing, dynamics and regulation of EGA, using different model organisms. 
Embryonic transcription initiates at a species-specific time, which ranges in vertebrates from 1 to 2 cell 
cycles in mouse, to cell cycles 6-9 in Xenopus and zebrafish embryos (Lee et al. 2014). Though, from an 
absolute time perspective EGA occurs rather later in the mouse, as the first cell division occurs a long time 
after fertilization. Among invertebrates, embryonic transcription starts at cell cycle 2 in the nematode C. 
elegans and at cell cycle 6 in the fruit fly D. melanogaster (Lee et al. 2014). A common sequence in EGA 
across model organisms is the activation of transcription in two waves. In the first wave only a few 
embryonic mRNAs are transcribed, whereas in the second, later wave, the bulk of transcription occurs. 
The dynamics of these two waves vary between organisms. In mouse and in C. elegans, the second wave 
of transcription rapidly proceeds the first, whereas in the fruit fly there is a long pause between the waves, 
with the first at cell cycle 6 and the major wave only at cell cycle 13, where the embryo consists already 
of roughly 6000 cells (Lee et al. 2014). 
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Different models have been proposed to explain the regulation of EGA, including the nucleocytoplasmic 
(N/C) ratio model, the maternal clock model and the transcript abortion model.  The N/C ratio model 
postulates that for EGA to begin, an EGA repressor in the cytoplasm must be titrated away, as the nuclear 
to cytoplasmic ratio increases during cell divisions (Newport and Kirschner 1982). One candidate repressor 
to be regulated by titration is xDnmt1 in Xenopus early embryos, whose molecular function will be 
discussed later. The maternal clock model, in contrast, is cell-cycle independent and hypothesizes that the 
accumulation or increase in activity of an EGA activator to a certain threshold is needed to start EGA, 
rather than the titration of a repressor (Lee et al. 2014). One example for the regulation by a maternal 
clock is TAF-4, a C. elegans TFIID subunit, whose activity is controlled by a fertilization-dependent 
mechanism. The transcript abortion model proposes that the properties of the cell cycle control early 
gene expression. In many organisms the first embryonic divisions occur very fast, cycling only between S 
and M phases and lacking the gap phases of the cell cycle. The transcript abortion model postulates that 
during such fast cell cycles, zygotic transcripts are aborted and can only be fully transcribed when the cell 
cycles lengthen (Tadros and Lipshitz 2009). The abortion of a nascent long transcript was, indeed, 
observed during early divisions in Drosophila (Shermoen and O'Farrell 1991). Further experimental 
evidence comes from studies, where a block of the cell cycle leads to premature EGA in Xenopus 
(Kimelman et al. 1987) and Drosophila embryos (Edgar and Schubiger 1986). It is tempting to speculate 
that EGA regulation by the cell cycle is more important in organisms with fast embryonic divisions, like 
Drosophila with early mitotic cycles of 8 minutes only, whereas could be less relevant in organisms with 
slow embryonic divisions, like mice, where the first two cell cycles take 2 days. However, the short length 
of early transcribed genes is conserved among species (Heyn et al. 2014), including mice, leaving the 
questions open if gene length is also restricting gene expression in early mouse embryos. In summary, the 
three general EGA models are not mutually exclusive and it is possible that a combination of them allows 
the tight regulation of EGA. The recent identification of critical EGA repressors and activators has shed 
some light into the molecular mechanisms controlling EGA. When considering the major changes that 
have to occur from a transcriptionally silent oocyte, with tightly packed DNA, to an early embryo 
undergoing rapid DNA replication and transcription, it is perhaps not surprising that mechanisms, which 
globally regulate DNA packaging and transcription, have been identified to be crucial for the 
reprogramming during OET. In addition, although little is known about post-transcriptional regulation of 
reprogramming, recent examples highlight the contribution of RNA regulation to a successful OET. 
Examples for the transcriptional and post-transcriptional regulation of reprogramming will be presented 
in the following.  
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2.1.4 Transcriptional regulation of reprogramming 
Histone variants 
Changes in the chromatin regulate the accessibility of transcription factors to DNA and, thus, transcription. 
Heterochromatin contains tightly packed DNA with a limited access by the transcription machinery. In 
contrast, euchromatin is loosely packed, allowing a relatively easy access to DNA. Chromatin is established 
by the packing of DNA into nucleosomes, and is influenced by nucleosome composition and epigenetic 
modifications on histone tails of the nucleosomes. Nucleosomes consist of four histone core proteins 
(H2A, H2B, H3, H4), which can be exchanged by variant histones with unique regulatory properties. 
Histone exchange, from repressive gamete-specific histones to somatic histones, is likely contributing to 
the establishment of a permissive chromatin state in embryos. It was shown in mouse that the repressive 
macroH2A variant in the female pronucleus is progressively lost after fertilization and during EGA onset 
(Chang et al. 2005). Similarly, studies from Drosophila showed that an early embryonic and germline-
specific H1 variant, named dBigH1, is exchanged for a somatic version during embryonic development, 
coinciding with the transcriptional activation (Perez-Montero et al. 2013). Consequently, the loss of 
dBigH1 leads to a precocious activation of Pol II-dependent transcription in the early embryo (Perez-
Montero et al. 2013).  
Chromatin remodelers 
Another type of chromatin regulation that influences gene expression is the nucleosome positioning, 
which is mediated by chromatin remodeling complexes. The finding that the remodelers contribute to 
EGA came from the mouse, as the loss of maternal Brg1 protein, a catalytic subunit of the SWI/SNF 
chromatin remodeler complex, leads to a reduced transcription of 30 % of embryonic genes and 
embryonic-arrest (Bultman et al. 2006). However, the question remains whether Brg-1 contributes to a 
general opening of chromatin or whether Brg1 might be specifically targeted to the promoters of 
embryonic genes, making them accessible for the transcription machinery.  
Epigenetic modifications: Histone marks 
As indicated earlier, chromatin can be also influenced by specific modifications of histone tails in the 
nucleosomes, either promoting or repressing transcription. An enrichment of the activating histone 
H3K4me3 mark was found on embryonic gene promoters, preferentially on those with house-keeping 
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roles that are expressed in Xenopus and Zebrafish embryos after EGA onset (Akkers et al. 2009; 
Vastenhouw et al. 2010; Lindeman et al. 2011). In contrast, the repressive histone H3K27me3 mark was 
present on the promoters of later expressed genes with developmental roles. This suggests a role for 
these histone modifications in distinguishing earlier vs. later expressed embryonic genes. Another 
interesting finding is the appearance of these histone marks only at the time of active transcription in the 
early embryos (Li et al. 2014; Vastenhouw et al. 2010; Akkers et al. 2009), indicating the presence of a 
relatively unmodified, naïve chromatin state of the embryo before EGA in several species. Therefore, 
histone marks likely do not contribute to the transcriptional regulation of the first embryonic genes, but 
rather direct gene expression later during embryonic development.  
Epigenetic modifications: DNA methylation 
In mammals, also DNA methylation is thought to contribute to EGA regulation. DNA methylation is the 
addition of a methyl group to cytosines in CpG dinucleotides, and methylation of promoter sequences is 
thought to have a repressive effect on transcription. Consistent with a repressive function, studies in 
mouse have reported a global DNA demethylation shortly after fertilization and during EGA, which might 
contribute to an open pluripotent chromatin state (Paranjpe and Veenstra 2015). However, in other 
vertebrate species the opposite trend was reported: zebrafish and Xenopus embryonic genomes appear 
to be globally hypermethylated during EGA (Paranjpe and Veenstra 2015). In addition, no obvious 
correlation between DNA methylation and transcriptional repression of genes seems to exist in Xenopus 
embryos (Bogdanovic et al. 2011). The DNA methyltransferase xDnmt1 was identified in Xenopus as an 
EGA repressor (Stancheva and Meehan 2000), though its silencing function appears to be independent of 
its catalytic activity and it is suggested that Dnmt1 acts as a direct transcriptional repressor before the 
onset of EGA (Dunican et al. 2008). In sum, the contribution of DNA methylation dynamics to EGA 
regulation may vary from species-to-species.  
Alternative promoters 
An important contribution towards understanding the link between chromatin modifications and 
transcription comes from studies using cap analysis of gene expression (CAGE) in early zebrafish 
development to map transcription start sites (TSSs) (Nepal et al. 2013; Haberle et al. 2014). CAGE data 
showed differences in the TSS usage between maternal and embryonic transcripts and identified an A/T-
rich (W-box) motif upstream the maternal TTSs and G/C-rich regions downstream of zygotic TSSs, with 
the two motifs often co-existing in promoters of constitutively expressed genes. This suggests that specific 
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sequences, presumably via recruitment of specific transcription factors, direct the dynamic use of 
maternal and embryonic TSSs during the OET. Interestingly, H3K4me3-marked nucleosomes are 
positioned specifically at G/C-rich embryonic sequences, which provides a link between chromatin 
remodeling and sequence information. It remains to be determined which transcription factors bind these 
motifs. The use of alternative promoters during the OET has also been reported from a study in mouse, 
where retrotransposons that are highly expressed in mature oocytes and early embryos, can serve as 
alternative promoters and first exons for embryonic genes (Peaston et al. 2004). This results in the 
production of early embryo-specific chimeric transcripts. The production of such chimeric transcripts has 
been reported for a number of host genes and it remains to be shown how widespread this type of 
regulation is.  
Transcription factors 
The availability of both general (pioneering) and more specific transcription factors has been found to 
contribute to the regulation of embryonic gene expression. In addition, work from different model 
organisms has shown that the regulation of Pol II initiation and elongation, as well as of components of 
the pre-initiation complex (PIC), contribute to EGA control (Zurita et al. 2008). The activity of Pol II can be 
regulated via phosphorylation of serine residues of tandem repeats on the C-terminal domain (CTD). 
Particularly the phosphorylation of Serines 2 and 5 of the CTD is crucial during the initiation and elongation 
of gene transcription. Pol II phosphorylation in mouse correlates well with transcription states during the 
OET. Transcriptionally silent oocytes show decreasing levels of CTD phosphorylation, whereas after 
fertilization phosphorylation increases again before EGA (Bellier et al. 1997). Another level of Pol II and 
PIC component regulation is their cellular localization. Pol II and PIC components have been shown to 
localize to the oocyte cytoplasm in many organisms and only after their nuclear translocation in early 
embryos, the general transcription machinery becomes active. One example is the sequestration of TAF-
4, the C. elegans TFIID subunit, by two repressors called OMA-1 and OMA-2 in the cytoplasm of the one- 
and two-cell embryo (Guven-Ozkan et al. 2008). Responsible for the inhibitory function of OMA-1/-2 is 
the fertilization-dependent phosphorylation by MBK-2. This phosphorylation ultimately leads to OMA-1/-
2 degradation at the four-cell stage and the release of TAF-4 into the nucleus, where assembly of TFIID 
can occur and transcription begin. 
The establishment of an open chromatin state and the activation of the basal transcription machinery 
during OET provide permissive mechanisms for EGA to occur. However, it is expected that other repressive 
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and activating transcription factors provide instructive mechanisms to gene expression and mediate fine-
tuning of transcription during embryo development. The identification of transcription factors with an 
intrinsic chromatin remodeling function, like Zelda in D. melanogaster, suggests that both regulatory 
mechanisms can even occur at the same time. Zelda is a maternally deposited transcription factor that 
binds to a heptamer motif, called TAGteam motif, in early embryonic gene promoters and activates their 
transcription (Liang et al. 2008; De Renzis et al. 2007; ten Bosch et al. 2006). Loss of Zelda leads to a failure 
in the activation of over a hundred embryonic genes, and defects in cellularization and pattern formation 
in the early embryo (Liang et al. 2008). In addition to the activation of these early genes, Zelda associates 
with the promoters of a thousand genes, whose transcription occurs later in embryonic development, 
suggesting a broader role for Zelda in licensing genes for transcription (Harrison et al. 2011; Nien et al. 
2011). Indeed, Zelda was recently found to mediate chromatin accessibility and can therefore be seen as 
a pioneer transcription factor, facilitating transcription factor binding genome-wide (Schulz et al. 2015). 
Also in zebrafish, transcription factors that likely possess pioneering activity have been discovered to 
contribute to EGA. They include the pluripotency transcription factors Nanog, Pou5f3 (formerly Pou5f1, 
an Oct4 homolog) and Sox19b (a Sox2 homolog), which have been found before to mediate 
reprogramming to iPS cells (Takahashi and Yamanaka 2006). Their combined loss leads to a failure in the 
activation of more than 75% of early embryonic genes and developmental arrest of zebrafish embryos 
before gastrulation (Lee et al. 2013). The observed correlation between the chromatin association of 
Pou5f3 and Sox2, and the enrichment in H3K4me3 and Pol II binding, suggest that these transcription 
factors, like in ES and iPS cells, also function during early development as pioneering factors to facilitate 
de novo gene expression (Leichsenring et al. 2013). In addition, it must be noted that many EGA activators, 
like Zelda and the pluripotency transcription factors Nanog, Pou5f3 and Sox19b, also contribute to the 
maternal mRNA clearance, by activating the expression of factors mediating mRNA degradation; for 
example the expression of microRNA miR-430 is activated by Nanog (Lee et al. 2013). Thus, these 
transcription factors provide a connection between the mechanisms driving EGA and maternal product 
degradation.  
Concluding, transcriptional regulation of reprogramming plays a critical role during the OET (the involved 
factors are illustrated in Figure 2.1 and summarized in Table 2.1). The regulation of chromatin and basal 
transcription machinery provide mechanisms to globally control transcriptional competence in germ cells 
and early embryos. However open remaining questions are: How is specificity of gene regulation 
achieved? What marks embryonic genes as active and maternal genes as inactive? What induces the 
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switch from maternal to embryonic gene expression? What determines the level and spatial regulation of 
embryonic gene expression? The dynamic use of maternal and embryonic transcription start sites 
provides one exciting possibility how differential transcription can be achieved. However, the molecular 
mechanisms underlying the differential expression, for example transcription factors recognizing the 
motifs, remain to be determined. Also the identification of the TAG team motif in early Drosophila genes 
and the identification of Zelda, as the associating TF, provided some insights into embryonic gene 
regulation. However, such motifs in embryonic gene promoters have not been identified in other model 
organisms. This raises the question how widespread and conserved the utilization of embryo-specific TF-
binding motifs is across organisms. 
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Figure 2.1 Integration of reprogramming-controlling mechanisms from different species in stereotypical cells 
(A) germ cell: chromatin is in a closed conformation, mRNA transcription is inactive, mRNAs are translationally repressed. (B) 
early embryos: mRNA transcription of embryonic genes from open chromatin can occur, activating (H3K4me3) and repressive 
(H3K27me3) histone marks are deposited to regulate gene expression, mRNAs are translated into proteins. Colors of the involved 
factors match to the color of the respective model organism (indicated in the square box). References are listed in tables 1.3.1 
and 1.3.2. Abbreviations: (TF) transcription factor, (TSS) transcription start site, (RNA Pol II) RNA Polymerase II, (PIC) pre-initiation 
complex, (CTD) C-terminal domain. 
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Type of 
regulation 
Name Organism 
Function 
during 
OET 
Molecular function Reference 
Histone 
variants 
 
macroH2A M. musculus 
EGA 
repressor 
Repressive H2A variant in 
germline and early embryo 
(Chang et al. 2005) 
dBigH1 
D. 
melanogaster 
EGA 
repressor 
Repressive H1 variant in 
germline and early embryo 
(Perez-Montero et al. 
2013) 
Chromatin 
remodeler 
Brg1 M. musculus 
EGA 
activator 
Catalytic subunit of the 
SWI/SNF chromatin 
remodeler complex 
(Bultman et al. 2006) 
Epigenetic 
modifier 
xDnmt1 X. laevis 
EGA 
repressor 
DNA methyltransferase 
activity is not required for 
EGA repression, might act 
directly as transcriptional 
repressor 
(Stancheva and 
Meehan 2000; Dunican 
et al. 2008) 
Alternative 
promoters 
unknown D. rerio both 
Maternal A/T-rich and 
embryonic G/C-rich TSSs lead 
to differential activation of 
genes during OET 
(Nepal et al. 2013; 
Haberle et al. 2014) 
Retro-
transposons, 
especially LTRs 
M. musculus 
EGA 
activator 
Retrotransposons act as 
alternative promoters in 
oocytes and embryos 
(Peaston et al. 2004) 
Basal 
transcription 
machinery 
TAF-4 C. elegans 
EGA 
activator 
TFIID subunit that is repressed 
before EGA 
(Guven-Ozkan et al. 
2008) 
TF with 
pioneer 
activity 
Zelda 
D. 
melanogaster 
EGA 
activator 
Activates transcription of 
embryonic genes, likely 
contains pioneer activity 
(Liang et al. 2008; De 
Renzis et al. 2007; ten 
Bosch et al. 2006; 
Harrison et al. 2011; 
Nien et al. 2011) 
Nanog, Pou5f3, 
Sox19b 
D. rerio 
EGA 
activator 
Activate transcription of 
embryonic genes, likely 
contain pioneer activity 
(Lee et al. 2013; 
Leichsenring et al. 
2013) 
Table 2.1: Transcriptional regulation of reprogramming during the OET 
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2.1.5 Post-transcriptional regulation of reprogramming 
RNA-binding proteins 
As described earlier, germ cells have the developmental capacity to develop into cells of all three germ 
layers, which in disease, is manifested in teratomas. Posttranscriptional regulation appears to play a 
predominant role in preventing such a precocious onset of pluripotency in germ cells. In mouse, as in 
worms, post-transcriptional mechanisms involving the activity of RNA-binding proteins (RBPs) were found 
to maintain the germ cell fate and inhibit precocious reprogramming. In mouse, DND-1 (dead end 1) 
prevents teratoma formation in the embryonic germ cells (Youngren et al. 2005). Loss of DND-1 leads to 
a failure in downregulating pluripotency genes, like Nanog or Oct4, and defective cell cycle arrest (Cook 
et al. 2011). Defects in cell cycle arrest likely result from a failure to protect mRNAs encoding cell cycle 
regulators, like p27Kip1 and p21Cip1, from microRNA-mediated degradation (Kedde et al. 2007). Comparable 
to the function of DND-1 in mouse, two C. elegans RBPs named GLD-1 (defective in germline development 
1) and LIN-41 (abnormal cell lineage 41) have been found to inhibit teratoma formation in the adult germ 
cells. Interestingly, GLD-1 and LIN-41 prevent germ cell reprogramming at two consecutive phases of 
oogenic differentiation. While GLD-1/Quaking functions earlier, maintaining the germ-line fate during the 
pachytene stage of meiosis I (Ciosk et al. 2006), LIN-41/TRIM-71 performs this function later, during the 
diplotene and diakinesis stages (Tocchini et al. 2014). Why different RBPs are employed at different 
developmental stages is not clear. One possibility is that LIN-41 takes the control from GLD-1 so that some 
of the GLD-1 mRNA targets, with OET-promoting functions, may be translated (Scheckel et al. 2012). 
Irrespective of the molecular details, common to gld-1 and lin-41 loss-of-function mutants is a premature 
entry of the meiotic cells into mitosis, followed by precocious EGA and teratomatous differentiation 
(Biedermann et al. 2009; Tocchini et al. 2014; Ciosk et al. 2006). In these mutants, the expression of early 
embryonic genes takes place before the expression of differentiation-specific genes (Tocchini et al. 2014). 
Moreover, just like in normal embryogenesis, the teratomatous differentiation, at least into muscles, 
depends on the maternally supplied transcription factor, PAL-1/Caudal, a master regulator for muscle fate 
in embryos (Baugh et al. 2005). All these observations suggest that the gld-1 and lin-41 teratomas reflect 
the function of GLD-1 and LIN-41 in delaying the onset of embryonic events until after fertilization.  How 
precisely they do it remains unclear. One key GLD-1 target is the cye-1 mRNA encoding cyclin E 
(Biedermann et al. 2009). By repressing this mRNA, and consequently preventing cyclin E translation, GLD-
1 regulates the activity of a key cyclin E partner, the cell cycle-driving kinase CDK-2. In gld-1 mutants, CDK-
2 is critical for the precocious mitosis, which is somehow linked with EGA (Biedermann et al. 2009). 
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Similarly, in lin-41 germlines, the translational de-repression of CDC-25.3, the activator of another cell 
cycle kinase called CDK-1, has been suggested to contribute to the premature entry into mitosis (Spike et 
al. 2014). Although in this case the connection between mitosis and EGA remains to be tested, GLD-1 and 
LIN-41 both repress premature mitosis, which appears to be linked to the transcriptional remodeling 
manifested by EGA and teratoma formation. Thus, a critical question for the future is whether there is a 
causal relation between the cell cycle and reprograming and, if yes, what is the underlying mechanism.  
Although the most-studied posttranscriptional regulators act as the repressors of reprogramming, RBPs 
could also act as activators. In Drosophila, another RBP, Smaug, has been reported to act as an EGA 
activator. The loss of Smaug leads to pleiotropic developmental defects in embryos, including the failure 
to start high-level embryonic transcription, possibly due to defects in the activation of the basal 
transcription machinery (Benoit et al. 2009). However, whether Smaug directly regulates the transcription 
machinery, or whether the failure to activate transcription is indirectly due to additional functions of 
Smaug in maternal mRNA degradation (Tadros et al. 2007), remains to be seen.  
P granules 
C. elegans P granules are germline-specific ribonucleoprotein granules with, typically, perinuclear 
localization, similar to germ granules or nuage in other organisms. It has been observed that, in gld-1 and 
lin-41 mutant germlines, but also in germlines undergoing a direct germ-to-soma-conversion (Tursun et 
al. 2011), the P granules disappear from differentiating cells. However, whether the loss of P granules is 
the cause or consequence of the somatic differentiation of germ cells remains controversial. A recent 
study, aimed at answering this question, used simultaneous knock-down of RBPs that nucleate P granule 
formation (Updike et al. 2014). This resulted in the expression of some somatic genes and differentiation 
into neurons after the ectopic expression of a neural fate master regulator called CHE-1. Thus, it seems 
that compromising P granules enhances the ability of germ cells to be reprogrammed into somatic cells, 
but, alone, is not sufficient to cause an OET-like transition, as observed in gld-1 and lin-41 mutant germ 
lines. Also, while in some cases the association of a given RBP with P granules may be important for the 
RBP activity (Voronina et al. 2012), in other cases, including GLD-1 or LIN-41, the significance of the 
association with P granules (if any) remains unknown. Finally, compromising P granules could affect the 
biogenesis of endo-siRNAs (endogenous small interfering RNAs), including  those facilitating the 
expression of germ-line genes (Gu et al. 2009; Cecere et al. 2014; Claycomb et al. 2009). Thus, the 
connection between P granules and the maintenance of the germ cell fate may be indirect. 
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In summary, post-transcriptional regulation appears to contribute to both, EGA/pluripotency repression 
in germ cells and EGA activation in early embryos (the involved factors are illustrated in Figure 2.1 and 
summarized in Table 2.2). RBPs have been found to serve as cytoplasmic roadblocks to reprogramming 
and thereby prevent a precocious pluripotent state in germ cells. Their identification in mice and worms 
suggests that this is likely a conserved regulatory paradigm. This is further supported by the common use 
of post-transcriptional regulation in oocytes, as oocyte development is associated with the entry into a 
transcriptionally silent state in most species. Common targets regulated by these RBPs are cell cycle genes, 
which indicates that they could be conserved targets for reprogramming regulation. The role of RNP 
granules in germ cell identity maintenance remains less well understood, as their impairment likely 
disturbs the function of many cytoplasmic regulators. 
 
Type of 
regulation 
Name Organism 
Function during 
OET 
Molecular function Reference 
RBPs 
DND-1 M. musculus EGA repressor 
Translational activator of the cell-
cycle genes p27Kip1 and p21Cip1, 
translational repressor of 
pluripotency genes like Nanog 
(Youngren et al. 2005; 
Cook et al. 2011) 
GLD-1 C. elegans EGA repressor 
Translational repressor of the 
cell-cycle gene CYE-1/CyclinE  
(Ciosk et al. 2006; 
Biedermann et al. 
2009) 
LIN-41 C. elegans EGA repressor Translational repressor (Tocchini et al. 2014) 
Smaug 
D. 
melanogaster 
EGA activator 
Activator of the basal 
transcription machinery, 
maternal mRNA degradation 
(Benoit et al. 2009; 
Tadros et al. 2007) 
Germ 
granules 
 
PGL-1, PGL-3, 
GLH-1, GLH-4 
C. elegans 
Somatic gene 
repressor 
Restrict the reprogramming of 
germ cells into somatic cells 
(Updike et al. 2014) 
Table 2.2: Post-transcriptional regulation of reprogramming during the OET 
 
 
20 
2.2 Caenorhabditis elegans: an elegant model to study the oocyte-to-
embryo transition 
Scientists have been using the nematode Caenorhabditis elegans to study many different aspects of 
animal development. Its short life cycle of approximately three days, the easy cultivation, the fully 
sequenced genome and a variety of genome editing tools provide many advantages. Features that make 
C. elegans especially suited to study germ cell development and the oocyte-to-embryo transition (OET) 
are its transparency, which allows direct observation of developing germ cells and embryos in live worms, 
the large number of progeny of up to 300 per hermaphrodite and the linearly ordered gonad with 
consecutive developmental stages. The C. elegans reproductive system, and in particular the process of 
oocyte maturation and the mechanisms controlling transcription during the OET are described below.  
2.2.1 The reproductive system 
C. elegans can have two different sexes, hermaphrodites and males. Hermaphrodites produce sperm 
during their last larval stage, which are then stored in the spermatheca. Adult hermaphrodites only form 
oocytes, which get self-fertilized by their stored sperm, unless they mate to males. Male sperm have 
specific features with which they can outcompete the hermaphrodite sperm, thereby enabling the 
exchange of genetic material between animals. The reproductive system of the hermaphrodite consists 
of two symmetrical U-shaped gonad arms ending in a common uterus (Figure 2.2). The distal part of the 
gonad contains actively dividing nuclei in a syncytium and provides a continuous supply of cells to create 
the gametes (Ellis and Kimble 1994). This pool of stem cells is controlled by the distal tip cell (DTC), which 
surrounds the distal gonad and sends proliferation signals (Kimble and White 1981). In the medial gonad 
region, the cells enter meiosis and undergo cellularization around the loop region. These cells differentiate 
into oocytes and arrest at diakinesis of meiotic prophase. The very proximal oocyte before the 
spermatheca (also called -1 oocyte) undergoes maturation and is finally pushed into the spermatheca to 
get fertilized. This process is very rapid with one oocyte getting fertilized every 23 minutes (McCarter et 
al. 1999). The zygote is then released into the uterus, where it completes several embryonic divisions until 
it is laid by the hermaphrodite. 
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Figure 2.2: The Caenorhabditis elegans reproductive system 
C. elegans hermaphrodites have two U-shaped gonad arms that end in a common uterus, where the embryos undergo early 
development, before being laid. The red box shows a close-up of one gonad arm. The distal tip cell (DTC) promotes proliferation 
of the germline stem cells. Subsequently, the mitotic cells enter meiosis and undergo differentiation into oocytes in the adult 
hermaphrodite. One oocyte after the other gets fertilized in the spermatheca and gives rise to a zygote that completes the meiotic 
division and then starts to undergo rapid mitotic divisions.  
 
2.2.2 Oocyte maturation 
The production of intact mature oocytes is required for a successful oocyte-to-embryo transition. Many 
coordinated processes drive the meiotic maturation of oocytes, which is defined as the cell cycle 
progression from diakinesis to metaphase of meiosis I. Cellular processes occurring during the meiotic 
maturation include nuclear envelope breakdown (NEBD), rearrangement of the cytoskeleton, and meiotic 
spindle assembly (McCarter et al. 1999). These processes are initiated by activation of the Maturation 
Promoting Factor (MPF), which is a well conserved key regulator of the meiotic cell cycle progression 
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(Masui 2001). The mechanisms regulating MPF activity are summarized below based on the knowledge 
from vertebrate systems, however, these mechanisms appear to be well conserved also in C. elegans (Von 
Stetina and Orr-Weaver 2011). MPF is composed of the Cyclin-dependent kinase Cdk1 and its regulatory 
subunit Cyclin B and is kept inactive in arrested oocytes by inhibitory phosphorylations at Thr14 and Tyr15 
on Cdk1 (Kim et al. 2013) (Figure 2.3). These inhibitory phosphorylations are added by the Wee1/Myt1 
kinases (Mueller et al. 1995) and can be removed by the phosphatase Cdc25 (Kumagai and Dunphy 1991) 
upon hormonal stimulation. Removal of the inhibitory phosphorylations activates MPF, which can then 
phosphorylate downstream substrates regulating the key cellular processes during meiotic maturation as 
described above. Metaphase exit requires the function of the anaphase-promoting complex (APC), an E3 
ubiquitin ligase, which induces cyclin B degradation and thereby leads to inactivation of MPF (Kim et al. 
2013).  
 
 
 
 
 
 
 
 
Figure 2.3: Regulation of the Maturation Promoting Factor in meiotic oocytes 
MPF is the key regulator of meiotic cell cycle progression. Its activity is regulated through phosphorylation, dephosphorylation 
and cyclin degradation. Abbreviations: (MPF) Maturation Promoting Factor, (Cdk1) Cyclin-dependent kinase 1, (APC) Anaphase-
Promoting Complex.  
In C. elegans, meiotic maturation is stimulated by the major sperm protein (MSP) (Miller et al. 2001; 
McCarter et al. 1999). Other important functions of MSP signaling in reproduction include the induction 
of gonadal sheath cell contraction that promotes ovulation and the activation of the mitogen-activated 
protein kinase (MAPK) signaling pathway (Miller et al. 2001). In addition, the RNA-binding proteins OMA-
1/-2 appear to be important for meiotic maturation and ovulation (Detwiler et al. 2001; Shimada et al. 
2002). Loss of OMA-1/-2 proteins leads to MAPK inactivation, defects in NEBD and a failure in the 
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localization of AIR-2, the C. elegans Aurora B kinase, to chromatin. OMA proteins appear to function 
upstream of the MPF in meiotic maturation (Detwiler et al. 2001).  
2.2.3 Transcriptional control during the oocyte-to-embryo transition 
A global repression of mRNA transcription in oocytes is common among diverse species. In C. elegans 
mRNA transcription is shut down when oocytes enter diakinesis and the transcriptional quiescence is 
maintained until the four-cell stage embryo (Kelly et al. 2002; Schisa et al. 2001; Seydoux and Dunn 1997). 
In embryonic germ cell precursors, transcription continues to be silenced until after the 100-cell stage 
(Mello et al. 1992). The event of transcription initiation in the early embryo is called embryonic genome 
activation (EGA). The transcriptional and post-transcriptional mechanisms controlling EGA in different 
animal models have been summarized in the previous chapter. Here, I focus just on those mechanisms 
that have been identified to regulate the general transcription machinery during the OET in C. elegans 
(summarized in Figure 2.4). Polymerase II (Pol II)-mediated mRNA transcription is a multi-step process 
that starts with the pre-initiation complex (PIC) assembly, consisting of Pol II, general transcription factors 
(GTFs) and the multi-protein complex Mediator (Blackwell and Walker 2006). Subsequent transcription 
steps depend on the phosphorylation of the Pol II C-terminal domain (CTD) on serine 5 (PSer5) during 
initiation and serine 2 (PSer2) during elongation, and are followed by transcription termination. C. elegans 
germ cells are transcriptionally active until diakinesis, when transcription is shut down by an unknown 
mechanism. Meiotic maturation, occurring in the last oocyte before the spermatheca, then appears to 
stimulate transcription initiation specifically. This has been observed by the accumulation of PSer5, but 
not PSer2, in wee-1.3-depleted oocytes, which undergo precocious maturation, due to premature CDK-1 
activation (Walker et al. 2007). Maturation-dependent PSer5 accumulation in oocytes is inhibited by FCP-
1, a phosphatase that likely recycles phosphorylated Pol II, and by a ubiquitination pathway involving the 
E1 ligase UBA-1 (Walker et al. 2007). Transcriptional inhibition in the one-and two-cell embryo is mediated 
via inhibition of TAF-4, a subunit of the general TFIID, by sequestration of TAF-4 in the cytoplasm by OMA-
1/-2 zinc finger proteins (Guven-Ozkan et al. 2008). Degradation of the OMA proteins in the four-cell 
embryo leads to release of TAF-4 into the nucleus, where transcription can start. Transcription repression 
in the embryonic germ cells precursors is maintained by PIE-1, another zinc finger protein (Mello et al. 
1992; Seydoux and Dunn 1997). PIE-1 interferes with transcription elongation by inhibiting CDK-9, the 
kinase responsible for Ser2 phosphorylation in embryos (Zhang et al. 2003). Consistent with a block in 
elongation, Pser5 positive loci are present in those germ cell precursors (Seydoux and Dunn 1997).  
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Figure 2.4: Transcriptional control during the OET in C. elegans 
Germ cells are transcriptionally active until diakinesis, when transcription is inhibited by an unknown mechanism (filled dots 
indicate phosphorylated serines, empty dots indicate unphosphorylated serines). Maturation induces transcription initiation, 
indicated by Ser5 phosphorylation, but not elongation. Accumulation of Pser5 in mature oocytes is inhibited by the phosphatase 
FCP-1 and an ubiquitin pathway involving the E1 ligase UBA-1. In one-and two-cell embryos, transcription is inhibited by 
sequestration of TAF-4, a TFIID subunit, in the cytoplasm. EGA is initiated in the four-cell embryo, except for the embryonic germ 
cell precursor, where transcriptional silencing is maintained by PIE-1. The upper row summarizes the transcriptional states in 
germ cells, the lower row in embryonic blastomeres. Abbreviations: (RNA Pol II) RNA Polymerase II, (CTD) C-terminal domain. 
 
2.3 Small RNA pathways 
Small RNAs have been proven to be of fundamental importance for many biological processes across 
model organisms. They serve as an adaptive immune system against viral infections, regulate 
development and life span, prevent transposon mobilization and modulate the expression of endogenous 
genes, among others. In eukaryotes there are three major classes of small RNAs: microRNAs (miRNAs), 
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Piwi-interacting RNAs (piRNAs) and small interfering RNAs (siRNAs). Although these classes differ in their 
biogenesis and their mode of target regulation, they share mechanistic principles in which small RNAs 
guide Argonaute proteins to complementary target sequences to regulate their expression at the 
transcriptional or post-transcriptional level. The induction of gene silencing by antisense RNA, a 
mechanism known as RNA interference (RNAi), was first discovered in Caenorhabditis elegans (Fire et al. 
1998). Since then, the nematode proved to be a very valuable model organism to study small RNA biology. 
Recent advances include especially the discovery of the diversity of endogenous siRNAs and their 
regulatory mechanisms. Endogenous siRNAs can be distinguished from exogenous siRNAs by the source 
of RNA they are made of. Exogenous siRNAs are processed from exogenous dsRNA and mainly play a role 
in the antiviral defense mechanism. Endogenous siRNAs are produced from endogenous dsRNA and 
regulate the expression of repetitive elements, pseudogenes and mRNAs. Endogenous siRNAs 
predominantly appear to play a role in the germline. In the C. elegans germline two siRNA pathways have 
been identified, the WAGO (worm argonaute) pathway and the CSR-1 (chromosome-segregation and 
RNAi-deficient-1) pathway. Although the two pathways share biogenesis components (Table 2.3), they 
differ considerably in their targets and functional outputs and will be therefore described separately in 
the following sections. 
2.3.1 The WAGO pathway 
The WAGO pathway is named after the worm-specific Argonaute proteins, which load the endo-siRNAs in 
this pathway. It mostly silences its targets, including repetitive sequences, transposons and a few protein-
coding mRNAs (Gu et al. 2009). Silencing of WAGO targets occurs at the post-transcriptional and 
transcriptional level and can even result in RNA-induced epigenetic silencing (RNAe), the 
multigenerational inheritance of silencing (Buckley et al. 2012). The WAGO pathway can be further 
separated into three different upstream pathways that commonly use the WAGOs as downstream 
effectors (Figure 2.5). Two of these upstream pathways are dependent on ERI-1 (enhanced RNAi), a 3’-to-
5’-exonuclease (Kennedy et al. 2004; Lee et al. 2006). ERI-1 interacts with DCR-1 (dicer related-1) and 
forms together with the RNA-dependent RNA polymerase (RdRP) RRF-3, and additional components, the 
ERI (ERI-DCR-1) complex (Thivierge et al. 2011). The ERI complex produces a set of endogenous small RNAs 
that are 26 nucleotides in length with a guanosine at the 5’end (26G RNAs) (Ruby et al. 2006; Han et al. 
2009). Two different populations of 26G RNAs exist: sperm-26G RNAs, which are bound by the redundant 
Argonautes ALG-3 and ALG-4, and oocyte-26G RNAs, which are bound by ERGO-1 (Han et al. 2009; Conine 
et al. 2010; Vasale et al. 2010). ALG-3/4 26G RNAs are required for spermiogenesis, and loss of ALG-3/4 
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results in a temperature-dependent sterility of the animals (Han et al. 2009; Conine et al. 2010). ERGO-1 
26G RNAs appear to target predominantly zygotic transcripts during development and map to gene-poor 
chromosome arms and duplicated non-conserved genes (Han et al. 2009; Vasale et al. 2010; Fischer et al. 
2011). Loss of ERGO-1 only leads to minor defects in fertility, but mutant worms show the ERI phenotype 
(Yigit et al. 2006; Han et al. 2009). The third upstream pathway, which uses WAGOs as secondary effectors, 
is the PIWI-interacting RNA (piRNA) pathway. piRNAs are germ-line specific small RNAs of 21 nucleotides 
length with a 5’ uridine (Ruby et al. 2006). Their biogenesis differs considerably from that of 26G RNAs, in 
that they are produced by RNA Pol II. In addition, whereas 26G RNAs show perfect complementarity to 
their target transcripts, piRNAs only have a partial complementarity (Bagijn et al. 2012). Their production 
is initiated by Forkhead transcription factors (FKH) from two loci on chromosome IV or from promoter 
regions of protein-coding genes genome-wide (Ruby et al. 2006; Cecere et al. 2012). piRNAs associate 
with the PIWI protein PRG-1, whose loss results in a temperature-dependent sterility (Batista et al. 2008). 
Due to their role in transgene silencing, piRNAs are thought to silence “non-self sequences” and to 
participate in genome surveillance (Bagijn et al. 2012; Lee et al. 2012). However, while piRNAs can initiate 
the silencing, WAGO 22G RNAs are needed to maintain the silencing response (Lee et al. 2012; Ashe et al. 
2012; Shirayama et al. 2012). WAGO 22G RNAs are named after their length of 22 nucleotides and the 
presence of a guanosine at the 5’end and they are loaded by 12 semiredundantly functioning Argonautes 
of the WAGO clade (Gu et al. 2009). Loss of all 12 Argonautes in the MAGO 12 mutant leads to a depletion 
of basically all WAGO 22G RNAs and a temperature-dependent sterility of the animal (Gu et al. 2009).The 
production of WAGO 22G RNAs is DCR-1-independent, and occurs via RNA-dependent RNA polymerase 
(RdRP) complexes. These consist of the redundantly functioning RdRPs RRF-1 and EGO-1, the dicer-related 
helicase DRH-3, and a tudor-domain containing protein called EKL-1 (Gu et al. 2009). In addition, the 
WAGO 22G RNA production is partially dependent on the so-called Mutator foci, which are formed by the 
6 Mutator proteins MUT-16, MUT-7, MUT-8/RDE-2, MUT-2/RDE-3, MUT-15, and MUT-14 (Billi et al. 2014). 
Loss of any of these mutator proteins results in transposon upregulation, leading to a high germline 
mutation rate and sterility after several generations. Mutator foci likely serve as amplification centers for 
WAGO 22G RNAs by recruiting RdRP components (Billi et al. 2014). The WAGO pathway can induce 
downstream signaling via the nuclear RNAi pathway. This pathway mediates the transcriptional silencing 
of targets in the soma and germ line, via WAGO-12/NRDE-3 and WAGO-9/HRDE-1, respectively (Ashe et 
al. 2012; Buckley et al. 2012; Guang et al. 2010). 
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Figure 2.5: The WAGO pathway 
Different primary small RNA pathways function upstream of the WAGO pathway. They include the ERI-1-dependent ERGO-1 and 
ALG-3/4 26G RNA pathways and the 21U-piRNA pathway. Biogenesis of WAGO 22G RNAs occurs via the RdRPs RRF-1 and EGO-1 
and is dependent on the Mutator proteins. 22G RNAs are bound by WAGOs to associate with the targets of the respective 
upstream pathways. Abbreviations: (mRNA) messenger RNA, (lncRNA) long non-coding RNA, (RNA Pol II) RNA Polymerase II, 
(RdRP) RNA-dependent RNA polymerase, (WAGO) worm-specific Argonaute. 
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Small 
RNA 
5’terminus Argonaute Tissue Polymerase Biogenesis factors 
ERGO-1 
26G RNA 
monophosphate ERGO-1 
germline 
(oocyte), 
soma 
(embryo) 
RRF-3 
DRH-3, ERI-5, DCR-1, ERI-
1b, ERI-3, RDE-4 
 
ALG-3/4 
26G RNA 
monophosphate ALG-3/4 
germline 
(sperm) 
RRF-3 
DRH-3, ERI-5, DCR-1, ERI-
1b, ERI-3, RDE-4 
WAGO 
22G RNA 
triphosphate WAGOs 
germline,  
soma 
RRF-1, EGO-1 
DRH-3, EKL-1, Mutator 
proteins 
CSR-1 
22G RNA 
triphosphate CSR-1 germline EGO-1 DRH-3, EKL-1 
21U 
piRNA 
monophosphate PRG-1/2 germline RNA Pol II FKH-3/4/5, UNC-130 
Table 2.3: Features of the different endogenous siRNA pathways in C. elegans 
 
2.3.2 The CSR-1 pathway 
Although CSR-1 can induce target mRNA degradation via its slicing activity (Gerson-Gurwitz et al. 2016), 
the CSR-1 pathway is suggested to not commonly silence its targets, but rather promote their expression 
on the transcriptional level (Cecere et al. 2014). Consistent with this positive role on gene expression, the 
CSR-1 pathway is predicted to counteract the gene silencing mediated by the piRNA pathway by 
recognizing and licensing self-sequences for expression (Conine et al. 2010; Seth et al. 2013; Wedeles et 
al. 2013b). The current model for such gene activation is that CSR-1 interacts with Polymerase II in an 
RNA-dependent manner and influences chromatin organization, possibly by recruiting chromatin 
modifiers and histone methyltransferases that promote euchromatin formation (Wedeles et al. 2013a). 
Though, the precise mechanism of the gene activation remains unclear and chromatin modifiers 
interacting with CSR-1 have not been identified to date. The majority of CSR-1 22G RNAs are antisense to 
protein-coding genes, more specifically to thousands of germline genes (Claycomb et al. 2009). What 
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initially triggers their production is unclear, as no primary siRNAs or Argonautes in this pathway have been 
identified yet. Like the WAGO pathway, the CSR-1 pathway uses an RdRP complex for the biogenesis of 
22G RNAs (Figure 2.6). However, whereas WAGO 22G RNAs are redundantly produced by the RdRPs RRF-
1 and EGO-1, CSR-1 22G RNAs depend on EGO-1 alone for their production (Gu et al. 2009; Claycomb et 
al. 2009). DRH-3 and EKL-1 are shared components of the RdRP complexes for the WAGO and CSR-1 
biogenesis. The 22G RNAs are loaded into CSR-1, the only Argonaute functioning in this pathway 
(Claycomb et al. 2009). The abundance of a subset of CSR-1 22G RNAs is controlled by CDE-1, which 
uridylates and thereby destabilizes the 22G RNAs (van Wolfswinkel et al. 2009). CDE-1 is suggested to 
have a role in the separation of the WAGO and CSR-1 pathway, as the accumulation of CSR-1 22G RNAs in 
cde-1 mutants leads to defects in gene silencing, likely due to misloading of CSR-1 22G RNAs into WAGOs 
(van Wolfswinkel et al. 2009). Loss of CSR-1 is reported to result only in modest changes in gene expression 
(Claycomb et al. 2009), which is in contrast to the severe developmental defects that lead to sterility and 
embryonic lethality. These phenotypes are shared among mutants of the CSR-1 pathway, such as DRH-3 
and EGO-1. Germline defects specifically include underproliferation of mitotic cells, enlargement of the 
transition zone from mitotic to meiotic cells, chromosome segregation defects in diakinetic oocyte nuclei, 
and impaired sperm development (Smardon et al. 2000; Vought et al. 2005; Claycomb et al. 2009; Qiao et 
al. 1995; Conine et al. 2010). Embryonic phenotypes include poor metaphase alignment and chromosomal 
bridging at anaphase resulting in abnormally shaped nuclei and embryonic arrest before gastrulation 
(Smardon et al. 2000; Claycomb et al. 2009). These meiotic and mitotic defects have been originally 
attributed to the failures in chromatin organization. A significant contribution to embryonic lethality is 
suggested to come from the depletion of histones in CSR-1 pathway mutants, as overexpression of the 
core histones improved the survival rate of csr-1- and ego-1-depleted embryos (Avgousti et al. 2012). 
However, the recently reported CSR-1 endonuclease (slicing) activity, also contributes to normal 
embryogenesis, presumably by fine-tuning maternal mRNAs encoding for proteins with essential 
functions in the embryo (Gerson-Gurwitz et al. 2016). It has been observed, that increased levels of a 
microtubule depolymerase, called KLP-7, in CSR-1 slicer mutants lead to the microtubule defects observed 
in csr-1-depleted embryos. Required for the slicing activity is the DDH catalytic motif, which has been also 
shown to mediate mRNA cleavage by CSR-1 in vitro (Aoki et al. 2007). An additional negative regulatory 
role for CSR-1, is the translational repression of mRNAs (Friend et al. 2012). CSR-1 has been shown to 
interact with the PUF protein FBF-1 and the translation elongation factor eEF1A to repress FBF-1 target 
mRNAs. It remains unclear if this function is small RNA-dependent as depletion of other CSR-1 pathway 
components resulted in a less robust de-repression of FBF-1 targets. 
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Figure 2.6: The CSR-1 pathway 
It is not known what initially triggers the production of CSR-1 22G RNAs by the RdRP EGO-1. CSR-1 22G RNAs are antisense to 
more than 4000 germline-expressed genes. CSR-1 is the only Argonaute protein functioning in this pathway, which appears to 
usually not silence its targets, but rather promotes the expression of the germline-expressed genes. However, also negative 
regulatory functions of CSR-1 have been found, including the degradation of target mRNAs via its slicing activity. CDE-1 regulates 
the abundance of CSR-1 22G RNAs by triggering their degradation via uridylation. Abbreviations: (mRNA) messenger RNA, (RdRP) 
RNA-dependent RNA polymerase. 
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3 Results and Discussion 
3.1 Inhibition of embryonic gene expression in the Caenorhabditis 
elegans germline by the CSR-1 small RNA pathway 
with Cristina Tocchini and Michael B. Stadler 
In order to give rise to a new organism, the blastomeres of the early embryo must be developmentally 
flexible. This developmental plasticity, or pluripotency, is acquired during the so-called oocyte-to-embryo 
transition (OET), when a terminally differentiated cell, the oocyte, is reprogrammed, after fertilization, 
into an embryo constituted by undifferentiated and pluripotent cells. A precise regulation of this 
reprogramming event is critical, since germ cells that precociously acquire pluripotency can develop into 
germ cell tumors, called teratomas (Ciosk et al. 2006). This disease phenotype has been observed across 
species, from the nematode Caenorhabditis elegans to humans. In C. elegans, a teratoma is induced in 
the absence of the RNA binding proteins (RBPs) GLD-1/Quaking (Ciosk et al. 2006) or LIN-41/TRIM71 
(Tocchini et al. 2014). GLD-1 and LIN-41 inhibit a precocious germ cell reprogramming at consecutive 
meiotic stages of oocyte development, in pachytene-stage and diplotene/diakinesis-stages, respectively. 
Similar to the naturally occurring events during the OET, the reprogramming in gld-1 and lin-41 mutant 
germ cells is characterized by a re-entry into the cell cycle, followed by embryonic genome activation 
(EGA), and finally somatic-like differentiation into various cell types, such as muscles and neurons  
(Tocchini et al. 2014; Biedermann et al. 2009; Ciosk et al. 2006). Although the identification of GLD-1 and 
LIN-41 contributed to elucidating the mechanisms controlling pluripotency during the OET, our 
understanding is still far from being complete. Therefore, we decided to screen for additional repressors 
of pluripotency in the C. elegans germline. Interestingly, we find mutants showing EGA in the germline 
(later referred to as germline-EGA) without a cell cycle re-entry. In addition, the germlines of these 
mutants show expression only of early embryonic genes, but not of later-expressed differentiation-
promoting genes. The mutant alleles were mapped to the drh-3 and ego-1 genes, suggesting an 
involvement of endogenous small interfering RNA (endo-siRNA) pathways in embryonic gene repression 
in germ cells. By testing multiple endo-siRNA mutants for germline-EGA, we find that in particular one of 
the two C. elegans endo-siRNA pathways, employing the Argonaute CSR-1, is important for such a 
function. CSR-1 is the only worm Argonaute required for fertility and embryo survival (Yigit et al. 2006). It 
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has been suggested to function in diverse processes, including chromosome segregation (Claycomb et al. 
2009; Yigit et al. 2006), chromatin organization (Maine et al. 2005; She et al. 2009), histone mRNA 
processing (Avgousti et al. 2012), germ granule formation (Claycomb et al. 2009; Updike and Strome 
2009), alternative splicing (Barberan-Soler et al. 2014), and exogenous RNAi (Yigit et al. 2006). CSR-1 binds 
small RNAs that are complementary to germline-expressed genes (Claycomb et al. 2009) and it is 
suggested to promote expression of its target genes (Cecere et al. 2014). Moreover, CSR-1 is predicted to 
counteract gene silencing, by recognizing and licensing self-sequences for expression (Seth et al. 2013; 
Wedeles et al. 2013b; Conine et al. 2013). Reported negative regulatory roles of CSR-1 comprise the 
translational repression of FBF-1 target mRNAs in mitotic germ cells (Friend et al. 2012), and the 
degradation of maternal mRNAs via its conserved catalytic slicer residues (Gerson-Gurwitz et al. 2016; 
Yigit et al. 2006). In this study, we present a new role for CSR-1 in inhibiting the precocious expression of 
embryonic genes in the C. elegans germline, and show that this function is mediated via its slicing activity. 
These findings suggest that CSR-1 is important during the OET to delay embryonic transcription to its 
physiological onset in early embryos. 
3.1.1 Results  
Identification of new pluripotency repressors 
To better understand how pluripotency is controlled in the C. elegans germline we performed a genetic 
screen to discover new pluripotency repressors. It was previously observed that the reprogramming of 
germ cells to pluripotency in gld-1 mutants was accompanied by a precocious onset of EGA (Biedermann 
et al. 2009), linking pluripotency to EGA. Moreover, the identification of pluripotency repressors based on 
a precocious EGA in germ cells has been recently proven to be a valuable tool, through the identification 
of the RNA binding protein LIN-41 as a pluripotency repressor (Tocchini et al. 2014). Therefore, in this 
screen, we continued to use EGA as a marker for pluripotency. EGA is monitored with an EGA-GFP 
reporter, expressing GFP from the promoter of a very early expressed embryonic gene (vet-4), resulting 
in an embryo-specific expression in wild type worms. To identify novel regulators, we screened for mis-
expression of the EGA reporter in the germline (Figure 3.1A). We discovered three independent mutants 
(alleles rrr2, rrr5, and rrr9) expressing the EGA-GFP reporter precociously in germ cells (Figure 3.1B). By 
performing complementation group assays between our newly identified mutants, as well as with gld-1 
and lin-41 mutants, we verified the novelty of the identified regulators, and discovered that the EGA 
phenotype in the rrr2 and the rrr5 mutant is caused by an alteration in the same gene (Figure 3.1C). 
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Figure 3.1: Identification of new pluripotency repressors 
A. Schematic representation of the genetic screen enrolled to identify pluripotency repressors in the adult C. elegans germline. 
As a readout for pluripotency an EGA-GFP reporter was used (green, showing embryonic transcription). Wild-type animals express 
the GFP reporter in embryos. Mutant animals abnormally express the reporter in germ cells.  B. Fluorescent micrographs of live 
animals expressing the EGA-GFP reporter. Here, and in the subsequent figures, gonads are outlined with a continuous line, 
embryos with a dashed line and asterisks mark the distal end of the gonad. Wild type animals express the embryonic reporter 
specifically in embryos, whereas mutant animals precociously express it in developing oocytes. Scale bar: 40 µm. C. 
Complementation matrix of newly identified mutants rrr2/rrr5/rrr9 and previously identified pluripotency repressors gld-1 and 
lin-41. For the complementation crosses we used the putative null alleles gld-1(q485) and lin-41(rrr3). “WT” indicates 
complementation, “EGA” indicates non-complementation. The mutant alleles rrr2 and rrr5 do not complement each other. 
 
 
34 
EGA occurs independently of the cell-cycle  
Previously, EGA was shown to occur in gld-1 and lin-41 mutant germ cells that start to undergo meiosis, 
but then re-enter into the mitotic cell cycle and differentiate into a teratoma (Francis et al. 1995; Ciosk et 
al. 2006; Tocchini et al. 2014). In contrast to the gld-1 and lin-41 phenotypes, the newly identified mutants 
were able to give rise to oocyte-like cells with condensed chromosomes (Figure 3.2A), suggesting the entry 
of the cells into diakinesis and a normal progression through meiosis. In wild-type oocytes, centrosomes 
are eliminated during meiotic progression (Mikeladze-Dvali et al. 2012). If the mutant oocytes undergo a 
normal meiosis, we thus expected the elimination of centrosomes in those cells. We monitored the 
presence of centrosomes by staining for the centrosome component SPD-2. We observed that SPD-2 was 
absent in rrr2 mutant oocytes, like it was in wild-type oocytes (Figure 3.2A), indicating the normal 
elimination of centrosomes and a meiotic progression of the mutant oocytes. In addition to being a 
subsequent event of the re-entry of germ cells into mitosis, EGA has also been observed as a result of 
precocious oocyte maturation in wee-1.3-depleted oocytes (Allen et al. 2014). Oocyte maturation, the exit 
of meiosis in oocytes, occurs in wild-type gonads in the last maturing oocyte, and is characterized by 
nuclear envelope breakdown (NEBD), cytoskeletal rearrangements and meiotic spindle assembly 
(McCarter et al. 1999). To test, if EGA in the mutant oocytes is the result of a precocious oocyte 
maturation, we examined their nuclear envelopes. To visualize nuclear envelopes, we followed the 
localization of EMR-1, a protein present in nuclear envelopes, by using an emr-1-mCherry transgene 
(Morales-Martinez et al. 2015). NEBD was observed, as reported before, in maturing oocytes in wild type 
animals (Figure 3.2B). Mutant oocyte-like cells expressing EGA-GFP, however, showed intact nuclear 
envelopes (Figure 3.2B). In sum, the mutant oocytes appeared to progress normally through meiosis and 
did not undergo precocious oocyte maturation, suggesting that EGA occurs independently of cell cycle 
events.  
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Figure 3.2: Precocious EGA is cell cycle-independent and limited to early expressed embryonic genes in the newly identified 
mutants 
A. Fluorescent micrographs of wild type and rrr2 mutant gonads, immunostained for the centrosomal component SPD-2 and 
DAPI. The medial view shows the presence of centrosomes in distal meiotic germ cells in wild type. The proximal views show wild 
type and rrr2 mutant oocytes, where no SPD-2 staining could be detected, indicating the elimination of centrosomes. Scale bars: 
10 µm. B. DIC micrographs of live animals, either wild type or rrr5. Scale bar: 30 µm. Boxed areas are enlarged on the right and 
show EGA-GFP reporter expression or expression of an EMR-1-mCherry transgene to visualize nuclear envelopes. In wild type, 
oocytes show EMR-1 localization to the nuclear envelope, except for the -1 oocyte that underwent nuclear envelope breakdown. 
rrr5 mutant oocytes, which express the EGA-GFP reporter, have intact nuclear envelopes. Scale bar: 20 µm. C. Detection of EGA 
transcripts by qRT-PCR. “Early embryonic”: mRNAs, which are expressed immediately after the onset of EGA. Each bar represents 
the mean of three independent biological replicates. Error bars represent the standard error of the mean (SEM). The significance 
of the differences has been calculated with the Student’s t-test: “*”, p<0.05; “n.s.”, not significant. D. Detection of somatic 
lineage-specific transcripts by qRT-PCR. The respective tissues and representative transcripts are indicated. Each bar represents 
the mean of three independent biological replicates. Error bars and p-values calculated as in C.  
Mutants express early embryonic transcripts, but not lineage-specific transcripts 
To characterize the extent of embryonic transcription in mutant gonads, we examined the levels of the 
endogenous vet-4 and additional embryonic transcripts using reverse transcription and quantitative PCR 
(RT-qPCR). We found that early expressed embryonic transcripts (Baugh et al. 2003), including vet-4, were 
highly upregulated in rrr2 mutant gonads compared to wild type (Figure 3.2C). Somatic lineage-specific 
transcripts which are expressed later during embryonic development, however, are not upregulated in 
rrr2 mutant gonads (Figure 2D). These findings indicate that rrr2 mutant gonads specifically express early 
embryonic transcripts, but not transcripts involved in somatic differentiation. This observation is in 
contrast to what has been shown for gld-1 and lin-41 mutant gonads, where the maternal transcription 
factor PAL-1, which drives muscle differentiation in embryos (Hunter and Kenyon 1996), leads to 
differentiation of the reprogrammed germ cells into muscles (Tocchini et al. 2014; Ciosk et al. 2006). Thus, 
the mutant germ cells appear to undergo only a first reprogramming step, resulting in the expression of 
early embryonic genes, but do not undergo a full reprogramming to pluripotency. Being able to separate 
EGA from an additional reprogramming step, leading to teratoma formation in gld-1 and lin-41 mutants, 
provides the unique opportunity to study EGA repression separately, uncoupled from additional 
phenotypes. 
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Figure 3.3: EGA repression in the germline is mediated via the CSR-1 pathway 
A. Schematic view of the drh-3 and ego-1 gene structures with highlighted known protein domains and their putative functions. 
Arrows indicate the locations of the identified mutations. The drh-3(rrr2) mutation is intronic, likely leading to a splice-donor 
variant. The drh-3(rrr5) mutation is located in exon 10 is causing a precocious stop codon (Q647>Stop). The ego-1(rrr9) mutation 
is located in exon 12 and leads to a nonsynonymous amino acid change (A1271>V). B. Western blot analysis of wild type and 
different drh-3 mutant protein lysates probed for DRH-3 and ACT-1 (as a loading control). No full-length DRH-3 protein could be 
detected in the drh-3(rrr2) and drh-3(rrr5) protein lysates. Drh-3(tm1217) is a putative null allele (containing a 482 bp deletion) 
which was used as a negative control. Drh-3 homozygous populations were obtained by worm sorting. C. Detection of EGA-GFP 
reporter expression in mutants belonging to the WAGO or CSR-1 pathway, as well as shared components of both pathways. Each 
bar represents the percentage of animals that express the reporter in germ cells. N>30. Fluorescent micrograph of a live csr-
1(tm892) mutant, grown at 25°C, expressing the EGA-GFP reporter abnormally in developing oocytes. Scale bar: 40µm. D. 
Detection of EGA transcripts in wild type, a strain containing mutations in all 12 WAGOs (MAGO12) and csr-1(tm892) mutants by 
qRT-PCR. Each bar represents the mean of three independent biological replicates. Error bars represent the SEM. The significance 
of the differences has been calculated with the Student’s t-test: “*”, p<0.05; “n.s.”, not significant. 
The CSR-1 pathway functions in EGA repression 
We mapped the mutants to drh-3 (dicer-related-helicase-3, alleles rrr2/rrr5) and to ego-1 (enhancer-of-
GLP-ONE-1, allele rrr9) (Figure 3.3A and Figure S3.1), both functioning in small non-coding RNA pathways. 
All mutants seem to behave like molecular nulls, as they display fully penetrant sterility, which was 
reported earlier for putative drh-3 and ego-1 null alleles (Duchaine et al. 2006; Smardon et al. 2000). In 
addition, examining DRH-3 protein levels in drh-3(rrr2/rrr5) mutants by western blot, did not reveal the 
presence of the protein in neither of the two mutants (Figure 3.3B). In the C. elegans germline, two main 
endo-siRNA pathways have been reported to function, each employing different Argonautes: the WAGO 
(worm argonaute) pathway and the CSR-1 (chromosome-segregation and RNAi-deficient-1) pathway (Gu 
et al. 2009; Claycomb et al. 2009). These Argonautes bind specific classes of small RNAs, which are 22 
nucleotides in length with a guanosine at the 5’end (22G RNAs)(Gu et al. 2009). 22G RNAs are produced 
by RNA-dependent RNA polymerases (RdRPs) and act as secondary effectors of the endo-siRNA pathways. 
DRH-3 is a core component present in all RdRP complexes and therefore important for the biogenesis of 
all classes of 22G-RNAs (Gu et al. 2009). EGO-1 functions redundantly with another RNA polymerase, 
called RRF-1, in the production of WAGO 22G-RNAs (Gu et al. 2009). For the production of CSR-1 22G 
RNAs, EGO-1 alone is required (Claycomb et al. 2009), suggesting that loss of the CSR-1 pathway function 
is responsible for the EGA phenotype. To confirm this hypothesis, we decided to examine the expression 
of the EGA reporter in mutants that are specific for either WAGO or CSR-1 pathway functions. Different 
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primary siRNA-pathways function upstream of the WAGO pathway and use the RdRP complex for the 
production of secondary 22G RNAs to amplify their response. They include the maternal ERGO-1 and 
spermatogenesis-specific ALG-3/4 26G RNA pathways (Vasale et al. 2010; Han et al. 2009; Conine et al. 
2010), as well as the piRNA pathway (Bagijn et al. 2012; Lee et al. 2012; Luteijn et al. 2012). To address if 
the EGA reporter expression is the result of disrupting the 26G RNA pathways, we looked at EGA 
expression in eri-1(mg366) mutant germlines lacking 26G RNAs (Han et al. 2009). To test the involvement 
of the piRNA pathway in EGA repression, we used prg-1(tm892) mutants, lacking most piRNAs (Wang and 
Reinke 2008). Neither eri-1 nor prg-1 mutants showed EGA reporter expression in the germline (Figure 
3.3C). In addition, loss of mut-2 and mut-7, essential components of the mutator foci which are required 
for WAGO 22G RNA amplification (Phillips et al. 2012; Gu et al. 2009; Zhang et al. 2011) did not cause a 
robust germline-EGA phenotype. In contrast, a high percentage of csr-1(tm892) mutants showed EGA-GFP 
expression in the germline, comparable to the identified ego-1(rrr9) mutant (Figure 3.3C). In addition, we 
tested putative drh-3 null alleles for EGA-GFP expression. Those mutants showed a similar percentage of 
germline-EGA expressing worms to the drh-3(rrr2) and drh-3(rrr5) mutants, which further suggested that 
our drh-3 mutants behave like null mutants. To verify the results of our EGA reporter assay also for 
endogenous embryonic genes we used qRT-PCR. MAGO12 is a strain that combines mutants of all 12 
WAGO genes (Gu et al. 2009) and can therefore be seen as a complete loss-of function of the WAGO 
pathway activity. We determined early embryonic transcript levels in this mutant and in the csr-1(tm892) 
mutant, where the loss of the only Argonaute in this pathway abolishes the function. We found that the 
embryonic transcripts we tested were highly upregulated in csr-1 compared to wild type gonads, whereas 
no changes appeared in MAGO12 mutant gonads (Figure 3.3D). Together, these results suggest that it is 
the disruption of the CSR-1 endo-siRNA pathway that determines the germline-EGA phenotype. 
A transcriptional regulation of the EGA reporter 
Post-transcriptional gene regulation via the 3’ UTR of an mRNA is a major mode of gene regulation in the 
germline (Merritt et al. 2008). We therefore wanted to examine if the EGA reporter is regulated via its 
3’UTR. For the reporter we used the endogenous promoter and 3’UTR sequences of the embryonic gene 
vet-4. To distinguish between a transcriptional, promoter-dependent, versus a post-transcriptional 
regulation via the 3’UTR of our EGA reporter, we exchanged the gene-specific vet-4 3’UTR to an 
unregulated tbb-2 3’UTR. Exchanging the 3’UTR still resulted in the expression of the reporter in mutant 
germ cells, but not in the wild type ones (Figure 3.4A). We concluded that the regulation of our reporter 
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is dependent on its promoter. This suggested a transcriptional regulation of the reporter and likely also of 
the endogenous embryonic genes.  
 
 
 
 
 
 
Figure 3.4: Expression regulation of the EGA reporter is promoter-dependent  
Fluorescent micrographs of live animals expressing the Pvet-4::mCherry::tbb-2 3’UTR reporter. Drh-3(rrr5) heterozygotes express 
the reporter specifically in embryos, whereas drh-3(rrr5) homozygotes express the reporter abnormally in developing oocytes. 
Scale bar: 40 µm. 
Histone protein depletion does not cause EGA 
The above finding of the transcriptional regulation of the EGA reporter suggested that the loss one of the 
reported functions of the CSR-1 pathway in transcription or chromatin regulation might cause its 
precocious expression in germ cells. Among the functions potentially affecting chromatin formation, is the 
suggested role of CSR-1 in histone mRNA maturation (Avgousti et al. 2012). This study reported a function 
for the CSR-1 pathway in the processing of histone pre-mRNAs to mature mRNAs via binding of CSR-1 in 
an ego-1-dependent manner to histone pre-mRNA 3’UTRs and inducing their cleavage. Moreover, they 
report a severe depletion of histone proteins in CSR-1 pathway mutants resulting from the defects in 
histone pre-mRNA processing, which potentially results in a decreased histone incorporation into 
chromatin. We examined if our drh-3 mutants show such a decrease in overall histone protein levels by 
western blot analysis. However, a decrease in histone H2B levels in our drh-3 mutants and in the putative 
drh-3(tm1217) null mutant compared to wild type animals could not be detected (Figure 3.5A). It was 
unexpected that we did not observe a decrease in histone H2B levels in drh-3(tm1217) mutants, as this 
was reported before (Avgousti et al. 2012). We therefore wanted to interfere with histone protein 
production using a second approach. CDL-1 is the C. elegans histone stem-loop binding protein (SLBP) and 
it is required for the production of histone proteins (Keall et al. 2007). Consequently, RNAi knockdown of 
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CDL-1 leads to a severe depletion of histone proteins (Keall et al. 2007). If the reduction of histone protein 
levels is causing the germline-EGA, then the depletion of CDL-1 should give the same phenotype. We 
therefore examined the expression of our EGA reporter in cdl-1-depeted animals. EGA reporter expression 
in germ cells of cdl-1-depeted animals could, however, not be observed (Figure 3.5B). In sum, we did not 
detect a depletion of histone proteins in our drh-3 mutants and also interfering with histone protein 
production did not cause the EGA phenotype. We conclude that the depletion of histone proteins is 
unlikely to be the cause for EGA misregulation.  
The CSR-1 catalytic slicer activity is required for EGA repression 
Recently, CSR-1 has been reported to degrade maternal mRNAs encoding proteins with essential functions 
in the early embryo via its slicing activity (Gerson-Gurwitz et al. 2016). We therefore wanted to test if the 
slicing function contributes to embryonic gene repression. We performed qRT-PCR analysis on gonads for 
embryonic transcipts using a CSR-1 slicer-dead mutant, containing a single-copy integrated FLAG::CSR-1 
construct with the DDH catalytic slicer residues mutated to AAA in the csr-1(tm892) mutant background 
(Figure 3.5C). The CSR-1 slicer-dead mutant revealed upregulation of the tested embryonic transcripts to 
similar levels as detected in csr-1(tm892) null mutants (Figure 3.5C). This indicated that the slicer activity 
is required for EGA repression. The importance of such a post-transcriptional regulation by CSR-1 was 
surprising, because our previous results suggested a transcriptional regulation of embryonic genes, 
indicated by the transcriptional regulation of the EGA reporter. How can we explain the importance of a 
post-transcriptional function for the transcriptional repression of embryonic genes? One explanation is 
that CSR-1 does not target embryonic transcripts directly, but controls the transcription of embryonic 
genes by regulating upstream factors via the slicing activity. This would mean that embryonic genes are 
not among the CSR-1 target genes, which is expected given that most CSR-1 targets are germline-
expressed genes. To test this, we used a list of CSR-1 targets, which is based on the presence of gene-
specific complementary 22G RNAs that associate with CSR-1 (Claycomb et al. 2009). Using transcriptome 
profiling data from staged C. elegans embryos (Baugh et al. 2003), we identified a group of 446 early 
embryonic genes. Embryonic transcription in C. elegans starts at the 4-cell stage (Seydoux and Fire 1994). 
Therefore, we defined the early embryonic genes as genes, which are upregulated at least 2-fold from the 
4-cell to the 8-cell stage and from the 8-cell to the 15-cell stage, but are not present at the 4-cell stage, 
and are therefore not maternally deposited. Our analysis showed that the majority of early embryonic 
genes are not CSR-1 target genes (Figure 3.5D). Among the embryonic genes, which we tested previously 
by qRT-PCR only one, vet-6, appears to be a CSR-1 target. In sum, it seems unlikely that embryonic genes 
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are directly targeted by CSR-1 for degradation. We suggest that CSR-1 regulates via its slicing activity the 
abundance of a maternal mRNA, encoding for example a transcription factor or chromatin regulator, 
which contributes to the transcriptional regulation of embryonic genes. 
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Figure 3.5: The depletion of histones does not cause a precocious EGA, whereas inactivation of the CSR-1 slicer function does 
A. Western blot analysis of wild type and different drh-3 mutant protein lysates probed for H2B and PolyA-binding protein-1 
(PAB-1, as a loading control). A decrease in H2B protein levels in drh-3(tm1217) mutants, as described before in (Avgousti et al. 
2012), or in our newly identified drh-3(rrr2/rrr5) mutants, could not be detected. B. Fluorescent micrographs of live animals 
expressing the EGA-GFP transgene after control or cdl-1 RNAi treatment. Cdl-1 RNAi treated animals were sterile, producing only 
unfertilized oocytes. Like control RNAi treated animals, also cdl-1 RNAi treated animals did not show EGA-GFP expression in germ 
cells (1 out of 45 sterile animals). Scale bar: 30 µm. C. Schematic view of the CSR-1 protein with highlighted known protein 
domains. In red indicated are the DDH residues that confer the catalytic slicer function. In CSR-1 slicer-dead mutants DDH residues 
are mutated to AAA. Detection of EGA transcripts by qRT-PCR. csr-1(tm892) null mutants and csr-1; FLAG::CSR-1 AAA (slicer-dead) 
mutants show upregulation of early embryonic genes. Each bar represents the mean of three independent biological replicates. 
Error bars represent the SEM. D. Among a group of 446 early expressed embryonic genes, only 30 are considered to be CSR-1 
targets, based on the presence of antisense 22G RNAs associated with CSR-1 in pull-down experiments. 
 
3.1.2 Discussion 
A model to study EGA repression 
We report here the identification of mutants undergoing a precocious EGA in germ cells without a re-
entry into the cell cycle. Earlier studies of mutants showing EGA in the germline suggested that this is a 
cell-cycle dependent event, allowing the transcription of embryonic genes only after a re-entry into 
mitosis (Biedermann et al. 2009; Tocchini et al. 2014) or after a precocious oocyte maturation (Allen et al. 
2014). Being able to separate EGA from cell cycle events provides the unique opportunity to study the 
transcriptional repression of embryonic genes in germ cells without complicating the analysis by 
additional phenotypes due to cell cycle misregulation.  
In C. elegans embryos, repression of the basal transcription machinery has been implicated in EGA control. 
In one- and two-cell stage embryos, TAF-4, a TFIID subunit, is bound by the proteins OMA-1/2 and thereby 
sequestered in the cytoplasm to repress RNA Pol II-dependent transcription (Guven-Ozkan et al. 2008). In 
the four-cell stage embryo, when EGA onset occurs, the degradation of OMA-1/2 leads to the release of 
TAF-4 into the nucleus, where TFIID assembly can occur and transcription start. How transcriptional 
repression is mediated in germ cells remains unclear. Germ cells are transcriptionally active until 
diakinesis, when transcription is shut down by an unknown mechanism. The expression of embryonic 
genes in the oocytes of CSR-1 pathway mutants suggests that these are transcriptionally active. This is 
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supported by the finding that the EGA reporter is transcriptionally regulated. However, a transcriptional 
activity of the mutant oocytes has to be confirmed further. Transcriptional activity can be monitored by 
the phosphorylations occurring at the C-terminal domain (CTD) on RNA Polymerase II (RNA-Pol II). During 
transcription initiation the CTD is phosphorylated on serine 5 (PSer5); during elongation the 
phosphorylation shifts to serine 2 (PSer2). Thus, the transcriptional activity can be monitored using 
antibodies specific to PSer5 and PSer2 (Seydoux and Dunn 1997). By performing immunostainings with 
these antibodies, we can therefore address the question if the mutant oocytes show globally active 
transcription. In addition, the transcription should be dependent on other factors involved in Pol-II 
mediated transcription, such as components of the pre-initiation complex (PIC) or the kinases 
phosphorylating the serines on the Pol II CTD. The dependence of the expression of the EGA reporter on 
these factors could be answered by simultaneous knockdown with CSR-1 pathway components. If the 
mutant oocytes show indeed active transcription, then further questions include if they remain 
transcriptionally active, despite the entry into diakinesis, or if they undergo de novo Pol II activation.  
Reported CSR-1 functions and their contribution to EGA repression 
The CSR-1 pathway has been implicated in many different functions in the germline. In our study, we 
addressed the possible contribution of some of them to EGA control. First, we tested if the suggested 
function of CSR-1 in histone mRNA maturation (Avgousti et al. 2012) could be required to repress a 
precocious EGA in oocytes. However, we could not detect a global decrease in histone protein levels in 
our drh-3 mutants. Moreover, the depletion of CDL-1, the C. elegans stem-loop binding protein, which 
leads to a drastic decrease in histone proteins (Keall et al. 2007), did not cause a precocious EGA. 
Therefore, histone protein depletion does likely not account for the EGA phenotype. A reported negative 
regulatory role of CSR-1 in the FBF-1 pathway (Friend et al. 2012) is equally unlikely to contribute to EGA 
repression. FBF-1 is only expressed in mitotic germ cells (Crittenden et al. 2002) and thus not present in 
developing oocytes, where the precocious EGA occurs. In addition, this function appears to be small RNA-
independent, as the defects in translational repression in csr-1 mutants, were not (or much less) observed 
in mutants of the RdRP complex factors DRH-3 and EGO-1. Though, the role of CSR-1 in EGA repression is 
likely small RNA-dependent, as precocious EGA is also observed in drh-3 and ego-1 mutants. Another 
suggested activity of CSR-1 is the contribution to chromatin organization by regulating the incorporation 
of the centromere-specific histone H3 protein (CENP-A) and by regulating chromatin modifiers or histone 
methyltransferases (Cecere et al. 2014; Claycomb et al. 2009). However, the contribution of CSR-1 to this 
function remains correlative and an interaction of CSR-1 with chromatin remodelers has not been 
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published to date. Also, a suggested function of CSR-1 in P granule (the C. elegans germ granule) formation 
does likely not cause the precocious EGA. The loss of perinuclear localization of P granules has been 
reported for csr-1 mutants and following the depletion of CSR-1 by RNAi knockdown (Claycomb et al. 
2009; Campbell and Updike 2015). In contrast, P granules seem to be unaffected when the CSR-1 slicing 
activity is lost (Gerson-Gurwitz et al. 2016). As we observed a precocious EGA in CSR-1 slicer mutants, P 
granule loss does not appear to contribute to this phenotype, assuming that the CSR-1 slicer mutant we 
used in the experiments behaves in the same way as the published mutant. In general, it remains to be 
controversially discussed to which extent the loss of CSR-1 affects chromatin organization and P granule 
formation, as its loss is not accompanied by the strong phenotypes associated with loss of chromatin 
factors or P granules. In fact, csr-1 mutant germ cells maintain germline characteristics and only subtle 
changes seem to occur in the transcriptome of csr-1 mutants (Claycomb et al. 2009). Thus, the conditions 
leading to ectopic somatic gene expression in germ cells after global chromatin misregulation (Patel et al. 
2012; Robert et al. 2014) or complete loss of P granules (Updike et al. 2014) differ considerably to the 
conditions where we see EGA. We observe EGA only in relatively normal looking oocytes, but not in 
strongly affected germ cells. Furthermore, CSR-1 is suggested to define transcribed genes in the germline 
as “self” and protect them from gene silencing by the piRNA pathway (Seth et al. 2013; Wedeles et al. 
2013b). This protective function appears to be negligible for EGA repression, as we did not observe EGA 
in prg-1 mutants, where piRNA function is abolished and silencing does not occur. Recently, the CSR-1 
slicing activity has been found to be essential for early embryogenesis, potentially by regulating the 
abundance of maternally loaded transcripts into the embryo (Gerson-Gurwitz et al. 2016). It is important 
to note that the above mentioned CSR-1 functions do not take into account this new reported role of the 
CSR-1 slicing activity. Thus, it remains unknown if they are dependent on this endonucleolytic function. 
We found that the slicing activity is important to inhibit a precocious EGA in developing oocytes. This 
suggests that the slicing activity is already required to maintain functional oocytes, and is not only 
necessary for embryogenesis. How the slicing activity contributes to EGA repression on a mechanistic level 
is not clear. However, it seems rather unlikely that CSR-1 directly degrades embryonic transcripts, as these 
are presumably not expressed in germ cells and as the majority of embryonic genes are not CSR-1 targets. 
We suggest that CSR-1 regulates the abundance of a germline transcript that is important for the 
transcriptional repression of embryonic genes, for example by degrading transcripts encoding 
transcription factors or chromatin regulators. Another possibility is that CSR-1 is not specifically regulating 
the transcription of embryonic genes, but has an effect on transcription in general. One interesting 
observation indicating a global regulation of Pol II-mediated transcription, is the upregulation of the 
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positive Transcription Elongation Factor b (pTEFb) subunit, CIT-1.2, in CSR-1 slicer dead mutants (Gerson-
Gurwitz et al. 2016). We attempt to identify a maternal target involved in transcription, by RNAi 
knockdown of candidate genes upregulated in the CSR-1 slicer-dead mutant and looking for a rescue of 
the EGA phenotype in csr-1 mutants. However, their identification is complicated by the decreased 
knockdown efficiency in csr-1 mutants, due to the function of CSR-1 also in the exogenous RNAi pathway. 
A similar RNAi screen for upstream candidates regulating EGA, based on up-and down-regulated genes in 
drh-3 mutants from our RNA-sequencing data (Figure S3.2), was hampered by the same decreased 
exogenous RNAi activity. 
Endogenous small RNA function in oocytes - a conserved mechanism? 
Endo-siRNAs can be found in mammals, although they are not produced by RNA-dependent RNA 
polymerases (RdRPs) like they are in worms. RdRPs were likely present in the common eukaryotic 
ancestor, but have been lost in several eukaryotes, including vertebrates and insects (Zong et al. 2009). In 
mammals, endo-siRNAs are produced from long dsRNAs by Dicer processing (Suh and Blelloch 2011). Loss 
of Dicer in mouse oocytes results in meiotic arrest with spindle and chromosome segregation defects 
resulting in sterility (Murchison et al. 2007; Tang et al. 2007). Due to the function of Dicer in both, 
microRNA and endo-siRNA biogenesis, it was initially unclear which small RNA pathway function is 
important, or if both of them are. However, it has been found that microRNA function is globally 
suppressed in mouse oocytes (Suh et al. 2010; Ma et al. 2010), indicating that the Dicer mutant phenotype 
results from the loss of endo-siRNAs. The production of endo-siRNAs in mouse oocytes is predominantly 
performed by an oocyte-specific Dicer isoform, DicerO, which lacks the N-terminal DExD helicase domain 
(Flemr et al. 2013). The deletion phenotype of DicerO alone is identical to that of the deletion of both Dicer 
forms, the somatic and oocyte one. The deletion of AGO2, the only mammalian Argonaute with slicing 
activity, results in a very similar phenotype in mouse oocytes and it has been recently shown that the 
slicing activity is essential for endo-siRNA function in oocytes (Stein et al. 2015). In sum, a function for 
endo-siRNAs and their catalytic Argonautes in the female germline appears to be conserved. If the endo-
siRNA pathway contributes in the mammalian germline, similarly to its function in the C. elegans germline, 
to EGA repression, remains to be addressed.  
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3.1.3 Supplemental figures 
 
 
 
 
 
 
 
 
 
 
Figure S3.1: Single-nucleotide variants in the mutants induced by EMS-mutagenesis 
After EMS-mutagenesis, all mutants were outcrossed against the wild type parental strain 5 to 8 times. Whole-genome-
sequencing (WGS) revealed sequence variants clustering mostly on chromosome I. Numbers indicate chromosomes and “M” 
mitochondrial DNA. WGS data was filtered by "high quality SNVs (single nucleotide variants) of EMS-type not found in parent".  
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Figure S3.2: RNA-sequencing data drh-3(rrr2) 
mRNA sequencing data from drh-3(rrr2) and wild type (N2) adult worms, performed in duplicates. The mean mRNA values were 
calculated and plotted along the y-axis (drh-3(rrr2)) and x-axis (N2). In red marked are 220 mRNAs going up more than 1.5-fold 
(log scale) in drh-3. In green marked are 256 mRNAs going down more than 1.5-fold (log scale) in drh-3. 
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3.2 A common function for CSR-1 and LIN-41 in EGA repression? 
with Pooja Kumari and Dimosthenis Gaidatzis 
A previous study from our lab described the role of the RNA-binding protein LIN-41 in EGA repression in 
developing oocytes (Tocchini et al. 2014). To understand the mechanism underlying the LIN-41-mediated 
regulation of EGA, we performed LIN-41 immunoprecipitation (IP) experiments followed by mass-
spectrometry analysis to identify interaction partners of LIN-41. Among others, CSR-1 was identified as an 
interaction partner, suggesting a common function of these proteins. Although LIN-41 appears to have an 
additional role in inhibiting the re-entry of germ cells into mitosis, CSR-1 and LIN-41 might function 
together to inhibit a precocious EGA. Here, we describe the interaction of the two proteins in more detail 
and present our approaches to understand the mechanism behind a potential cooperative regulation of 
EGA by LIN-41 and CSR-1.  
3.2.1 Results 
CSR-1 and LIN-41 Interaction 
We discovered the in vivo interaction of LIN-41 with CSR-1 by performing LIN-41 IP-mass-spectrometry 
analysis (Figure 3.6A). Importantly, this interaction appeared to be RNA-independent as binding of the 
two proteins was consistent after RNase treatment. To confirm a direct interaction of the two proteins 
and to map the interacting domains, we used a cell-free protein expression system to perform Co-IP 
experiments. N-terminally tagged CSR-1 and LIN-41 proteins were expressed from plasmids under the 
control of an SP6 promoter in wheat-germ lysates (Figure 3.6B). These lysates contain all components 
necessary for transcription and translation, but are depleted of other mRNAs. Therefore, proteins 
expressed in the lysate can be directly used for Co-IP experiments without the need of further purification. 
The in-vitro produced proteins were allowed to form complexes and then tested for an interaction by 
pulling down one protein with the beads and looking for the presence of the interaction partner in the 
pull down after several washes. To detect the proteins, they were separated by SDS-PAGE and visualized 
with antibodies for the respective tags. Using this approach, we could confirm that CSR-1 binds to LIN-41 
in an RNA-independent manner (Figure 3.6C).  
LIN-41 belongs to the TRIM-NHL proteins, named after the presence of a TRIpartite Motif (TRIM) and a 
NCL-1/HT2A/LIN-41 (NHL) domain. The N-terminally located TRIM motif contains a RING domain, two B-
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boxes and a coiled-coil domain (Figure 3.6D). In other TRIM-NHL proteins the TRIM motif has been 
suggested to function as an E3 ubiquitin ligase (Wulczyn et al. 2011). The TRIM motif is followed by a 
filamin domain with a so far unknown function in TRIM-NHL proteins (Wulczyn et al. 2011). Previous 
structure-function studies of LIN-41 showed that interfering with the RING or filamin domain function did 
not cause a precocious EGA in germ cells (Tocchini et al. 2014). The C-terminal part of LIN-41 contains the 
NHL domain, consisting of 6 NHL-repeats, which have been implicated in mRNA binding (Loedige et al. 
2014). The introduction of a few point mutations in the RNA binding surface of the NHL domain led to 
precocious EGA in the germline (Tocchini 2015). Therefore, a functional NHL domain seems to be required 
for the LIN-41-mediated EGA repression, suggesting the importance of its mRNA regulatory role. We 
tested if the NHL domain is required for the binding to CSR-1. We could confirm the association of the LIN-
41 NHL domain with CSR-1 in our Co-IPs (Figure 3.6E). As a positive control for our binding assay served 
the LIN-41 full-length protein, which was found to be associated with CSR-1 and as a negative control 
served GFP, which was not enriched in the CSR-1 IPs. 
Next, we set out to identify the CSR-1 domain required for the interaction with LIN-41. CSR-1, similar to 
other Argonaute proteins, features the so-called N (N-terminal) domain, a PAZ (PIWI-Argonaute-Zwille) 
domain, a MID (middle) domain and a PIWI (P element-induced wimpy testis) domain (Figure 3.6D) 
(Swarts et al. 2014). The N domain has been shown in other Argonautes to play a role in target RNA 
cleavage and in unwinding the guide-passenger small RNA duplex. The PAZ domain forms a nucleic-acid 
binding structure and binds the 3’end of the guide RNA. The MID domain forms a nucleotide-binding 
pocket and interacts with the 5’end of the guide RNA and is possibly required to recognize specific 5’end 
bases via the “nucleotide specificity loop”. Finally, the PIWI domain includes the catalytic slicer residues 
DDH, which are conserved in CSR-1 (Yigit et al. 2006). RNA cleavage mediated by this slicer residues is 
suggested to tune maternal transcript levels in the C. elegans germline to allow normal embryonic 
development (Gerson-Gurwitz et al. 2016). In addition, we found that the catalytic slicer activity of CSR-1 
is important for EGA repression (Chapter 3.1). Apart from the small RNA binding and RNA-cleavage 
activities, the MID and PIWI domains have been also implicated in protein binding: CSR-1 has been 
suggested to bind the Pumilio-related RNA-binding protein FBF-1 via these domains (Friend et al. 2012). 
We therefore tested if the CSR-1 MID-PIWI domain can bind to the LIN-41-NHL domain. Such interaction 
was indeed found in our experiments using a MID-PIWI construct for the IP and detecting associated 
proteins (Figure 3.6F). In sum, the in-vitro binding studies, show an interaction of the CSR-1 MID-PIWI 
domain with the LIN-41 NHL domain. 
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Figure 3.6: Interaction of CSR-1 and LIN-41 
A. CSR-1 was identified in LIN-41 immunoprecipitation (IP) experiments followed by mass spectrometry analysis. CSR-1 was 
present in samples where RNA was present (RNase -) and where RNA was degraded (RNase +), indicating an RNA-independent 
interaction. B. Schematic of the co-immunoprecipitation experiments. Proteins were produced from plasmids in wheat-germ 
lysates and allowed to form complexes for 2 hours on ice. Anti-myc-tag antibodies were bound for 1 hour at 4°C before applying 
the protein/antibody mix to magnetic beads. Proteins were eluted from beads and loaded on a SDS gel. Western blot analysis 
was done using MYC and FLAG antibodies as indicated. C. Co-immunoprecipitations of myc-CSR-1 (full) and flag-LIN-41 (full). Flag-
GFP was used as a negative control and experiments performed as described in B. “+” indicates the presence of the respective 
protein/RNase in the sample. LIN-41 co-immunoprecipitated with CSR-1 in an RNA-independent manner. D. CSR-1 and LIN-41 
proteins with indicated known protein domains. E. Co-immunoprecipitations of myc-CSR-1 (full) and flag-LIN-41-NHL. Flag-GFP 
was used as a negative control, flag-LIN-41 (full) as a positive control. The LIN-41-NHL domain co-immunoprecipitated with CSR-
1. F. Co-immunoprecipitations of myc-CSR-1-MID-PIWI and flag-LIN-41-NHL. Flag-GFP was used as a negative control, flag-LIN-41 
(full) as a positive control. The LIN-41-NHL domain co-immunoprecipitated with the CSR-1-MID-PIWI domain.  
 
Our primary goal is to make point mutations in vivo which will inhibit the binding of CSR-1 to LIN-41, but 
do not interfere with other functions of the proteins. Therefore, we aim to identify the amino acid residues 
that mediate the binding. To identify such amino acids, we made use of peptide microarray studies, 
performed by JPT Peptide Technologies. We provided the LIN-41 FIL-NHL domains, expressed and purified 
from insect cells. These proteins were labeled with a fluorophore and applied to a microarray consisting 
of 18 amino acid long overlapping peptides of CSR-1. Binding of the LIN-41 FIL-NHL domain to a CSR-1-
peptide on the array was determined by the presence of a fluorescent signal, after washing excess un-
bound protein off the microarray. The results were visualized in a heat-map diagram showing fluorescence 
intensities in a color-coded manner, from white (no binding) to red (strong binding) (Figure 3.7). As an 
internal process-control served normal human serum (NHS) and a murine anti-FLAG antibody, detected 
by secondary fluorescently-labelled anti-human and anti-mouse IgG antibodies. With this assay, the LIN-
41 FIL-NHL binding to several CSR-1 peptides was detected. Peptide positions that showed a high 
fluorescent intensity and an intensity dependent on the concentration of the LIN-41 FIL-NHL protein 
applied to the array, were considered as peptides likely interacting with the LIN-41 FIL-NHL domain (Table 
3.1). In addition, as the CSR-1 MID-PIWI domain was printed in duplicates on the array, the detection of 
identical peptides in both arrays gave more confidence on the specificity of the interaction. Using these 
filter criteria, we identified one peptide sequence (peptides 127 and 157) that we considered to be most 
likely mediating the interaction with the LIN-41 FIL-NHL domain. It has to be mentioned that the control 
serum and anti-FLAG antibody also led to increased fluorescence at the same peptide positions as the LIN-
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41 FIL-NHL domain. Therefore, the identified peptide hits have to be considered with caution, because 
the peptides detected as interacting with the LIN-41 FIL-NHL domain might represent peptides that are 
more easily bound by other peptides in general. Despite these concerns, we looked at the most promising 
peptide hit in more detail. The peptides 126 and 157 share a 9 amino acid sequence with the peptides 
prior to them (peptides 125 and 156), which also showed an increased fluorescence in the array. This 
suggested that the overlapping 9 amino acid sequence may mediate the binding. To gain more 
information on this 9 amino acid sequence, we performed homology modeling of the C. elegans CSR-1 
MID-PIWI domain based on the human Argonaute AGO2 structure. This modeling suggested that the 9 
amino acid motif is part of an α-helix structure in the CSR-1 PIWI domain (data not shown). However, the 
motif is not conserved in between CSR-1 and AGO2 and hence it is difficult to predict the structural 
contribution of these residues. A deletion of the whole 9 amino acid motif would likely affect the CSR-1 
structure and single residues to mutate are hard to predict. Due to the difficulties to predict the structural 
importance of the 9 amino acid motif and our concerns regarding the specificity of the interactions 
detected in the peptide microarray, we did not proceed to mutate this motif in vivo to look for a loss of 
the interaction of CSR-1 and LIN-41.  
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Figure 3.7: Peptide microarray – heat map diagram 
Heat map diagram of the incubation of the CSR-1 peptide microarray with LIN-41 FIL-NHL domain in 1 µg/mL or 0.2 µg/mL 
concentration or normal human serum (NHS) and mouse α-FLAG antibody as control. The mean fluorescence intensity values are 
shown as colors from white (no or low intensity), over yellow (middle intensity), to red (high intensity).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1: Peptide microarray – peptide hits 
The table summarizes the peptide hits that were identified in the peptide microarray. The respective peptide numbers and 
sequences are indicated in the table. The peptide hits were analyzed for the intensity of the fluorescent signal, the dependence 
of the fluorescent signal on the concentration of LIN-41 FIL-NHL protein applied to the array and the presence of the peptide hit 
in the duplicates of the CSR-1 MID-PIWI domain printed on the array. In addition, information on the location of the peptide 
sequence in the CSR-1 protein is indicated. The most interesting peptide sequence (peptides 127 and 157) is indicated in red.  
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What could be the functional mechanism of the interaction? 
As mentioned before, both, CSR-1 and LIN-41, inhibit a precocious expression of embryonic genes in the 
developing oocytes. This, together with the discovery of a direct physical interaction between the two 
proteins suggests a functional relationship in EGA repression. One possible relationship could be that CSR-
1 controls LIN-41 expression, or vice versa. To address this possibility, we examined the expression of a 
GFP-tagged LIN-41 rescuing construct in drh-3 mutants. LIN-41-GFP expression in drh-3 mutants showed 
no obvious changes in expression levels or expression pattern compared to wild type (Figure 3.8A). 
Although we observed the GFP-LIN-41 expression in drh-3 mutants, we also expect no obvious changes 
occurring in csr-1 mutants, because CSR-1 pathway mutants display the same phenotypes. The expression 
of CSR-1 was observed with an endogenously-GFP tagged CSR-1. In lin-41 heterozygote animals we 
observed a cytoplasmic, perinuclear localization of CSR-1, as reported before (Claycomb et al. 2009). In 
lin-41 homozygous animals we observed a very similar CSR-1 expression and localization until the proximal 
germline where a teratoma is formed (Figure 3.8B). Although subtle expression changes might be difficult 
to detect in these mutant backgrounds, the overall expression levels and localization patterns of the 
proteins did not change. Thus, LIN-41 and CSR-1 do not appear to regulate each other’s expression.  
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Figure 3.8: LIN-41 does not regulate CSR-1 expression, or vice versa 
A. Fluorescent micrographs of live animals expressing a GFP-LIN-41 construct. Wild type animals and drh-3(rrr2) mutants show 
comparable expression of LIN-41 in the germline. Gonads are outlined with a continuous line, embryos with a dashed line and 
asterisks mark the distal end of the gonad. Scale bar: 40 µm. B. Fluorescent micrographs of live animals containing an 
endogenously GFP-tagged CSR-1. Lin-41(rrr3)/+ heterozygote animals show cytoplasmic, perinuclear localization of CSR-1 in germ 
cells. Lin-41(rrr3) homozygous mutants show a similar CSR-1 expression and localization, except for the proximal germline where 
a teratoma is formed and thus, the germline-to-soma transition leads to a degradation of germline-specific components (Tocchini 
et al. 2014). Scale bar: 40 µm. 
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Another possibility for a common function of LIN-41 and CSR-1, is the requirement of LIN-41 in the CSR-1 
pathway. To address if LIN-41 could contribute to the biogenesis or stability of CSR-1 22G RNAs, we 
sequenced small RNAs from lin-41-depleted animals. As controls served samples from drh-3 and ego-1-
depleted animals, where major changes in small RNA abundance are expected due to their function in 
22G RNA biogenesis (Gu et al. 2009; Claycomb et al. 2009). Indeed, when we compared the small RNA 
reads detected in drh-3 and ego-1 knockdown animals compared to control animals, we could detect a 
depletion of endo-siRNAs targeting protein coding genes, which are expected to be comprised of mostly 
22G RNAs (Figure 3.9). Another small RNA class, called 21U RNAs (piRNAs), was increased. A similar 
decrease in endo-siRNAs antisense to coding genes and an enrichment in piRNAs has been observed in 
small RNA samples from drh-3 mutants before (Gu et al. 2009). The changes we saw in our knockdown 
animals are less dramatic compared to drh-3 mutants, which is likely caused by a partial knockdown 
efficiency due to the role of DRH-3 and EGO-1 in exogenous RNAi. Together, the changes in small RNA 
classes in drh-3 and ego-1 knockdown animals showed that our small RNA sequencing results are of good 
quality and would allow us to detect changes in small RNAs, also in the lin-41 knockdown animals. 
Depletion of LIN-41 resulted in a minor decrease in endo-siRNAs antisense to coding genes in replicate 
one, but not in replicate two. Together, lin-41-depletion did not result in consistent changes in small RNA 
classes (Figure 3.9). To have a more specific view on the effects on CSR-1 22G RNAs, we highlighted those 
small RNAs that have been identified to be associated with CSR-1 (Claycomb et al. 2009) in the small RNA 
scatter plots (Figure 3.10). In drh-3 and ego-1 knockdown animals, there is a decrease in CSR-1 22G RNAs 
detected in the second replicates only. This is likely due to a varying knockdown efficiency between the 
two replicates. In lin-41-depleted animals, CSR-1 22G RNA levels stayed the same. In parallel to small RNA 
sequencing, we sequenced total RNA from the same samples to correlate the changes in small RNAs with 
the effects on the corresponding mRNAs. Drh-3 and ego-1 knockdown did not have an effect on mRNA 
levels (Figure 3.11). However, as our RNA-seq data from drh-3(rrr2) mutants showed up- and down-
regulated genes (Figure S3.2), we presume this is due to the partial knockdown of the proteins. 
Knockdown of lin-41, in contrast, showed many up- and down-regulated mRNAs compared to control. 
This is expected given the very strong somatic- and germline phenotypes upon loss of LIN-41 and revealed 
an efficient knockdown of lin-41 in our samples. Unfortunately, the lack of changing mRNAs after drh-3 
and ego-1 depletion did not allow us to identify commonly misregulated genes with lin-41. Also, when 
analyzing the mRNA levels of those few genes with changing small RNAs in lin-41, we did not see changes 
in mRNA levels. In total, although an efficient knockdown of lin-41 was achieved, we could not detect 
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changes on small RNA levels in general, nor on CSR-1 22G RNA levels in particular. Therefore, it seems 
that LIN-41 does not play a role in CSR-1 22G RNA synthesis. 
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Figure 3.9: Small RNA populations detected in drh-3-, ego-1- and lin-41-depleted animals compared to control  
The plots show the percentage of reads mapping to different small RNA classes, sequenced from control (empty vector), drh-3, 
ego-1, and lin-41-depleted animals. The samples were processed in duplicates. 
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Figure 3.10: Small RNAs are not affected in lin-41-depleted animals 
The scatter plots show expression changes in small RNAs (log2) in drh-3-, ego-1-, and lin-41-depleted animals compared to control 
(empty vector RNAi). The samples were processed in duplicates. In red colored are CSR-1 22G RNAs, defined by the small RNAs 
associated with CSR-1 (Claycomb et al. 2009). Stars represent the small RNAs mapping to the respective RNAi constructs, as 
indicated in the legend. Changes in small RNA expression are detected in drh-3 and ego-1-depleted animals. Small RNAs in lin-41-
depleted animals show no major changes.  
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Figure 3.11: RNA sequencing of drh-3, ego-1 and lin-41-depleted animals 
The scatter plots show expression changes in mRNAs (log2) in drh-3-, ego-1-, and lin-41-depleted animals compared to control 
(empty vector RNAi). The samples were processed in duplicates. Drh-3 and ego-1-depleted animals show no changes in mRNA 
levels, probably due to a partial knockdown efficiency. Lin-41-depleted animals reveal big changes on the mRNA level, as expected 
from its strong soma- and germline-phenotypes, and indicates a successful knockdown.   
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CSR-1 binds to its targets in a 22G RNA-dependent manner. Thus, for a functional CSR-1 pathway, not only 
the biogenesis of 22G RNAs has to be intact, but also the loading of 22G RNAs to the Argonaute. To study 
a potential involvement of LIN-41 in the loading of 22G RNAs to CSR-1, we sequenced CSR-1-associated 
small RNAs from control and lin-41-depleted animals. The first replicate was collected from young adult 
animals and a second replicate from adult animals. The scatter plots showed strong changes in small RNA 
expression between the two replicates (Figure 3.12A). These differences can be likely explained by the 
sample harvesting from different stages. When comparing control animals to lin-41-depleted animals 
within one replicate, we did not see any changes in small RNA expression in young adults and only minor 
changes in adults. Moreover, when we compared the expression changes in between the two replicates, 
we could not detect any common changes (Figure 3.12B). Therefore, it seems that LIN-41 does not play a 
role in the loading of small RNAs to CSR-1.  
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Figure 3.12: Small RNA sequencing from CSR-1 complexes 
A. The pairwise correlation plots show the small RNAs (log2) detected in CSR-1 immunoprecipitation experiments from lin-41 
RNAi-treated animals compared to control (empty vector) RNAi-treated animals. Replicate 1 is collected from young adult worms, 
replicate 2 from adult worms. Strong changes in small RNA populations occur between the two replicates. However, small RNAs 
in lin-41 RNAi-treated animals correlate well with control RNAi-treated animals in the same replicate, indicating that lin-41 
depletion does not have an effect on the loading of small RNAs into CSR-1 complexes. B. Comparison of the expression changes 
in between the two replicates did not reveal common changes.  
 
3.2.2 Discussion 
The discovery of a direct interaction between the two EGA repressors LIN-41 and CSR-1 in vivo, led us to 
speculate about a common function of the two proteins in inhibiting a precocious EGA in the germline. 
We could confirm a direct interaction of the proteins in vitro and map the interacting domains to the LIN-
41 NHL domain and the CSR-1 MID-PIWI domain. The requirement of the LIN-41 NHL domain in EGA 
repression has been previously shown by introducing a few point mutations in the domain, which 
presumably abrogate its ability to bind mRNAs (Tocchini 2015). Also for the CSR-1 PIWI domain, we have 
shown an in vivo function in EGA repression. The DDH motif conferring the CSR-1 slicing activity is located 
in this domain and has been shown to be required to suppress a precocious EGA (Chapter 3.1). If the 
binding of the proteins via these domains is linked to their functions in EGA repression, is an interesting 
aspect to study in the future. To address the in vivo function of this interaction in EGA repression, it will 
be necessary to make point mutations that specifically interfere with the binding, but not with other 
functions of the two proteins. Our approach to identify the amino acid residues required for the binding 
by using peptide microarrays did not allow us to identify residues with high confidence to be tested in 
vivo. This is partially due to the limitations of the peptide microarray, which can only detect interactions 
mediated via the primary amino acid sequence of the peptides printed on the array, but does not take 
into account the structure of the proteins. Another reason is the lack of information of the CSR-1 structure. 
This worm Argonaute protein is not very well conserved to the human AGO2, for which structural 
information is available. Therefore, we could not get reliable information on the structure of a potential 
peptide hit identified in the array. Thus, structural information of CSR-1 is crucial to make informed point 
mutations in vivo, and especially the co-crystallization of the CSR-1 MID-PIWI domain with the LIN-41 NHL 
domain could depict the important residues for their binding.  
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In our attempts to identify a functional relevance of this interaction, we first tested if LIN-41 directly 
regulates the expression level or localization of CSR-1, or vice versa. However, LIN-41 expression in drh-3 
mutants and CSR-1 expression in lin-41 mutants appeared unaffected. We then tested the idea of LIN-41 
being involved in the CSR-1 small RNA pathway. We sequenced total small RNAs from lin-41-depleted 
animals to address a role of LIN-41 in small RNA biogenesis. In addition, we sequenced CSR-1 associated 
small RNAs in lin-41-depleted animals, to address a function of LIN-41 in the loading of small RNAs into 
CSR-1. However, neither total 22G RNAs, nor 22G RNAs loaded into CSR-1 were affected by LIN-41 
depletion, suggesting that LIN-41 does not play a role in the CSR-1 small RNA pathway.  
Another possibility how LIN-41 and CSR-1 could function together in EGA repression is via a role for CSR-
1 in the regulation of LIN-41 target mRNAs. Although, we did not test this possibility yet, I would like to 
present here some ideas for such a regulation. The ideas are based on a published role for CSR-1 in the 
FBF-1 pathway and on our discovery concerning the function of CSR-1 in EGA repression. In general, the 
abundance of a protein can be influenced on the mRNA level by the stability of the mRNA that is encoding 
the protein or by the translation rate of the mRNA. To distinguish between a function in mRNA stability 
or translation, we could perform ribosome profiling together with mRNA sequencing on csr-1- and lin-41-
depleted animals. Consistent mRNA levels, but decreased ribosomal occupancy argues for a regulation by 
translational repression, whereas decreased mRNA levels with similar ribosomal occupancy argue for 
target mRNA degradation. Based on the mechanistic functions that have been described for CSR-1, it could 
participate in either of the two mechanisms to regulate the abundance of LIN-41 targets. Concerning the 
role of CSR-1 in translational repression, it is reported that CSR-1 is required for target mRNA repression 
of another RNA binding protein, named FBF-1 (Pumilio), by interacting directly with FBF-1 and the 
translation elongation factor EFT-3 (eEF1A) (Friend et al. 2012). FBF-1 is expressed only in the mitotic 
region of the adult germline (Crittenden et al. 2002) and can therefore not function in developing oocytes. 
However, we can speculate that LIN-41 could function similarly to FBF-1, to guide CSR-1 to its target RNAs 
in developing oocytes. According to the function of CSR-1 in the FBF-1 pathway, CSR-1 could contribute 
to mRNA regulation via the inhibition of the eEF1A GTPase activity resulting in translational inhibition 
(Figure 3.13 A). However, it has to be mentioned that this function appears to be small RNA-independent, 
because the defects in translational repression have not been observed in mutants of the RdRP complex 
components DRH-3 and EGO-1. However, the role of CSR-1 in EGA repression is likely small RNA-
dependent, as the derepression of embryonic genes is similarly observed after loss of DRH-3 and EGO-1. 
Thus, the mechanistic functions of CSR-1 in EGA repression and in the FBF-1 pathway might differ. 
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Alternatively, CSR-1 could function in the degradation of LIN-41 target mRNAs. One possibility is that CSR-
1 directly functions in the degradation of the mRNAs via its conserved endonuclease (slicing) activity (Yigit 
et al. 2006), which we showed is important for CSR-1’s role in EGA repression (Figure 3.13B). Another 
possibility would be the recruitment of factors involved in mRNA deadenylation or decapping, resulting in 
degradation via exonucleolytic decay (Figure 3.13C). To test these ideas, we first need to identify target 
mRNAs of LIN-41 in the germline. LIN-41 RNA-immunoprecipitation (RIP) experiments have been 
performed in the lab and identified potential interacting mRNAs of LIN-41. After validating a direct 
interaction for some germline mRNAs with LIN-41, we could use those to address the question how they 
might be co-regulated by the LIN-41-CSR-1 complex.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Different models for a co-regulatory role of CSR-1 and LIN-41  
We propose that LIN-41 and CSR-1 can co-regulate target mRNAs in the germline, either A) by translational repression, where 
CSR-1 and LIN-41 could regulate eEF1A, similar to the function that has been reported for the CSR-1/FBF-1/eEF1A complex (Friend 
et al. 2012) B) by endonucleolytic cleavage of the target mRNAs mediated by the catalytic slicer activity of CSR-1 C) by recruiting 
additional regulators of mRNA stability, such as factors involved in deadenylation or decapping.  
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4 General Discussion 
The reprogramming occurring during the OET is a complex process and we are only at the beginning of 
understanding the underlying mechanisms. Work from various model organisms has shown that key 
processes appear to be conserved during the OET. They include the silencing of transcription in oocytes, 
which is followed by a reactivation of transcription in early embryos (embryonic genome activation, EGA), 
and the occurrence of EGA in two waves. The mechanisms controlling these processes work at the 
transcriptional and post-transcriptional levels and may vary between organisms. Thus, one future 
challenge is to address the conservation of the identified players and mechanisms. The discovery of the 
pioneering transcription factor Zelda, and its promoter-binding motif in embryonic genes, enhanced our 
knowledge about the transcriptional regulation of embryonic genes in Drosophila. However, DNA-binding 
motifs specific to embryonic genes, or the transcription factors binding to them, have not been identified 
in other model organisms, which leaves the question about the conservation of this mechanism open. 
Moreover, while some of the identified players establish a global transcriptional competence in early 
embryos, the mechanisms mediating specificity of gene expression remain poorly understood. 
Furthermore, posttranscriptional regulation during the OET remains largely unexplored, although it is 
expected to play an important role during the transcriptionally silent period preceding EGA. Advances in 
the understanding of the post-transcriptional mechanisms contributing to reprogramming mostly come 
from C. elegans. There, the RNA-binding proteins GLD-1 and LIN-41 have been identified to contribute to 
EGA regulation. This thesis provides evidence for the importance of another type of post-transcriptional 
regulation to control EGA, via endogenous-small interfering RNAs of the CSR-1 Argonaute pathway. 
Importantly, we find that the catalytic activity of CSR-1 to degrade RNAs is required for this function. 
However, the precise molecular mechanism and the conservation of this functions remain to be explored. 
Once the individual regulatory mechanisms contributing to EGA control are understood, the next 
challenge will be to understand the interplay between those mechanisms. While some regulatory 
hierarchies have been understood, for example the regulatory axis in C. elegans embryos connecting the 
post-translational modification of OMA-1 and OMA-2 proteins to the cytoplasmic retention of the 
transcription factor TAF-4, the connections between other types of regulatory mechanisms remain to be 
determined. Dissecting the mechanisms underlying reprogramming during the OET will not only enhance 
the understanding of one of the most important developmental events but can also help in understanding 
and treating diseases, in which uncontrolled reprogramming can lead to teratomatous differentiation or 
undifferentiated tumors. Moreover, the identification of novel players controlling reprogramming is of 
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potential interest for the production of induced pluripotent stem (iPS) cells. The production of iPS cells 
still remains inefficient, with 0.01% - 6% efficiency by transcription factor overexpression (Pasque et al. 
2011), and a huge effort goes into developing strategies to achieve a higher reprogramming efficiency. 
Basic research on reprogramming can contribute to this field by uncovering new molecular players and 
pathways, potentially with conserved human functions. 
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5 Annex 
5.1 Additional mutants identified in the mutagenesis screen 
5.1.1 Results 
As previously described in chapter 3.1, I performed an EMS mutagenesis screen using an embryonic gene 
reporter to identify mutants that precociously express the reporter in the germ cells and hence may have 
mutations in EGA repressor genes. In addition to the small RNA pathway components drh-3 and ego-1, 
described earlier, I identified two more potential EGA repressors. Furthermore, while performing the 
screen for EGA repressors, I also looked for EGA activators by screening for animals with embryos lacking 
the expression of the EGA reporter. I discovered one mutant showing such a phenotype. In this chapter, I 
will describe these additional mutants, with a preliminary description of their phenotypes and candidate 
mutations responsible for the defects in EGA regulation.  
Mutant phenotypes - EGA repressors 
The two potential EGA repressors, named rrr6 and rrr8 henceforth, showed, in addition to the precocious 
EGA reporter expression in germ cells, a fully penetrant sterile phenotype. However, they differ in their 
germline morphology. The rrr6 mutant germlines appeared to first make some relatively normal oocytes, 
but these oocytes did not persist until the proximal part of the germline, where individual cells could not 
be distinguished anymore (Figure 5.1). Although this phenotype was not characterized in more detail, the 
disappearance of individual cell shapes and the patchy expression of the EGA reporter in the proximal 
germline, reminded of the teratoma phenotype observed in lin-41 mutants. The rrr8 mutant germlines 
showed varying phenotypes (Figure 5.1). Some mutant animals contained an overall smaller germline, 
which might be attributable to decreased germ cell proliferation, and major defects that did not allow the 
formation of oocytes. The very proximal germline of those animals did not contain any cells, leaving a 
vacuole-like space. Other rrr8 mutant animals appeared to have a less affected germline, which allowed 
the formation of oocyte-like cells. However, these oocytes differed considerably from wild type oocytes 
in their size and overall morphology. In sum, the rrr6 and rrr8 mutant germlines are more strongly affected 
than the drh-3 and ego-1 germlines, suggesting further defects in germ cell development in these mutants, 
in addition to the precocious EGA.  
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Figure 5.1: rrr6 and rrr8 mutants express the EGA reporter precociously in germ cells 
Fluorescent and DIC micrographs of live animals. Wild type animals express the EGA reporter specifically in embryos, whereas 
rrr6 and rrr8 mutant animals precociously express the reporter in germ cells. Gonads are outlined with a continuous line, embryos 
with a dashed line and asterisks mark the distal end of the gonad. Arrowheads in the DIC micrograph indicate oocytes in the rrr6 
mutant and a vacuolous germ cell region in the rrr8 mutant. Scale bars: 40 µm. 
Mutant phenotype - EGA activator 
Early C. elegans embryos have been reported to continue their development without embryonic 
transcription, only with the maternally deposited gene products, until the 100-cell stage (Edgar et al. 
1994). We therefore expected mutant embryos that lack an essential EGA activator to continue their 
development until several cell divisions have occurred. In our screen, we initially identified potential EGA 
activators based on the inability of the mutant embryos to express the EGA reporter. As this could also 
lead to the identification of mutant embryos with severe developmental defects leading to an early 
embryonic arrest, we looked at the development of the mutant embryos in more detail. Phenotypic 
analysis of one mutant identified in the screen, named rrr7, showed that the mutant embryos have 
undergone several cell divisions during embryonic development (Figure 5.2A). Furthermore, as expected 
for an EGA activator mutant, these animals were embryonic lethal. To determine if the cause of the 
phenotype was coming from either oocytes or sperms, we mated rrr7 mutant hermaphrodites with wild 
type males and looked for a rescue of the phenotype. Wild type sperm could not rescue the phenotype, 
suggesting a maternal-effect embryonic lethality. rrr7 mutant germlines, however, showed no obvious 
defects (data not shown). To characterize the embryonic defects in more detail we performed time-lapse 
microscopy. I observed much slower embryonic divisions in the rrr7 mutant embryos compared to wild 
type (data not shown). This suggested that embryonic divisions in this mutant did not occur normally. 
Performing DAPI staining on the mutant embryos to visualize their DNA, revealed defects in chromosome 
segregation, indicated by the incomplete separation of the chromosomes, which led to the formation of 
so-called chromatin bridges (Figure 5.2B). Later stage embryos also showed differences in chromatin 
content, indicated by big size differences between the nuclei. In summary, although the rrr7 mutant 
fulfilled our initial screening criteria for an EGA activator, further analysis of the embryonic phenotype 
revealed severe defects in embryonic divisions and chromatin content, suggesting that the lack of EGA 
reporter expression in those embryos is likely the consequence of those other defects. 
 
 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
75 
Figure 5.2: rrr7 mutant embryos lack EGA reporter expression and show defects in chromosome segregation 
A. Fluorescent and DIC micrographs of live wild type and rrr7 mutant animals. Wild type embryos start expressing the EGA 
reporter, whereas rrr7 mutant embryos lack reporter expression. Embryos are outlined with a dashed line. Scale bars: 40 µm. B. 
DAPI staining of wild type and rrr7 mutant embryos to visualize DNA. rrr7 mutant embryos show defects in chromosome 
segregation, indicated by the incomplete separation of chromatin between two nuclei (nuclei are indicated by arrowheads). Wild 
type embryos show completely separated chromatin (nuclei indicated by arrowheads). Embryos are outlined with a dashed line. 
Scale bar 15 µm. 
Mapping of the mutants 
To identify the phenotype-causing genetic mutations, we performed whole-genome-sequencing (WGS) 
and single nucleotide variant (SNV) mapping. The WGS data was filtered for SNVs of EMS-type (often GC 
to AT or AT to GC transitions (Sega 1984)) and SNVs that were not found in the parent strain. This SNV 
mapping revealed a cluster of mutations in the rrr6 mutant on chromosome II (Figure 5.3). The phenotype-
causing mutation in this mutant is not identified yet. There are several nonsynonymous mutations in 
protein-coding genes, which are likely candidates to cause the phenotype (Table 5.1).  
The rrr7 mutant contained only four SNVs, located on chromosomes III and X and on mitochondrial DNA 
(Figure 5.3). Balancing the mutation with an hT2 balancer covering regions of chromosomes I and III 
(McKim et al. 1993), suggested the mutation on chromosome III to be the phenotype-causing mutation. 
This mutation is a nonsynonymous mutation in the coding region of the ran-2 gene (Table 5.1). RAN-2 is 
the C. elegans Ran GTPase-activating protein (RanGAP).  RanGAPs enhance Ran activity by exchanging a 
guanosine diphosphate (GDP) to a guanosine triphosphate (GTP). Previous studies of ran-2-depleted 
embryos showed an important role for ran-2 in mitotic spindle formation, chromosome segregation, 
nuclear envelope assembly, and co-migration of centrosomes with the male pronucleus (Askjaer et al. 
2002). The reported phenotypes after ran-2 depletion are very similar to the phenotypes we saw in our 
rrr7 mutant embryos, further confirming the mapping of the phenotype-causing mutation to the ran-2 
gene.  
The rrr8 mutant contains four SNVs of EMS-type on chromosome I (Figure 5.3). The location of the 
mutation to chromosome I was additionally suggested by balancing the mutation with the hT2 balancer. 
To identify the phenotype-causing mutation among these, we performed RNAi-knockdown of the 
respective genes (Table 5.1) on the EGA reporter strain. The depletion of usp-48 showed a similar 
phenotype to the rrr8 mutant. Furthermore, the reported usp-48 depletion phenotypes such as sterility 
and a protruding vulva phenotype also match the rrr8 mutant phenotypes. Therefore, the 
 
76 
nonsynonymous mutation in the usp-48 coding region is very likely causing the phenotype. Usp-48 
encodes a deubiquitinating enzyme (DUB) and belongs to the subclass of ubiquitin-specific proteases 
(USPs) (Papaevgeniou and Chondrogianni 2014). DUBs can remove monoubiquitin and polyubiquitin 
chains from proteins by cleaving the peptide or isopeptide bond between ubiquitin and the protein. 
Thereby DUBs can counteract the ubiquitination pathway and its canonical role in protein degradation. 
Usp-48 has been identified as a synthetic multivulva (SynMuv) suppressor gene suggesting a role for usp-
48 in vulval cell-fate specification (Cui et al. 2006). If the function of usp-48 in the ubiquitination pathway 
is important for this role remains unknown. As many SynMuv genes encode transcription factors and 
chromatin remodelers, usp-48 has been suggested to function rather at the chromatin-level.  
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Single-nucleotide variants (SNVs) in the mutants induced by EMS-mutagenesis 
After EMS-mutagenesis, all mutants were outcrossed against the wild type parental strain 5 to 8 times. Whole-genome-
sequencing (WGS) revealed SNVs clustering on chromosome II for the rrr6 mutant. The rrr7 mutant contains SNVs on 
chromosomes III, X and on mitochondrial DNA. The rrr8 mutant shows several SNVs on chromosome I. Numbers indicate 
chromosomes and “M” mitochondrial DNA. WGS data was filtered by "high quality SNVs (single nucleotide variants) of EMS-type 
not found in parent".  
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Table 5.1: Summary of the candidate mutations detected in the isolated mutants  
The table summarizes the SNVs detected in the rrr6, rrr7 and rrr8 mutants. WGS data was filtered by "high quality SNVs (single 
nucleotide variants) of EMS-type not found in parent". 
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5.1.2 Discussion 
The additional putative EGA repressors identified in the screen provide an opportunity to increase our 
understanding of the mechanisms that regulate EGA during C. elegans development. The phenotype-
causing mutation in the rrr6 mutant has not been identified yet, but the location has been mapped to 
chromosome II and likely candidates have been identified by SNV mapping. The EGA phenotype in the rrr8 
mutant is most likely caused by the mutation in usp-48. Usp-48 encodes for an ubiquitin-specific protease, 
which has been suggested to function in chromatin remodeling in C. elegans (Cui et al. 2006). If the 
function in the ubiquitin pathway, in chromatin remodeling, or an uncharacterized function of usp-48 
contributes to EGA regulation remains to be elucidated. Previous studies in our lab identified important 
roles of post-transcriptional gene regulation via RNA-binding proteins in the regulation of EGA (Ciosk et 
al. 2006; Biedermann et al. 2009; Tocchini et al. 2014). The function of the CSR-1 pathway in EGA control 
involves a post-transcriptional regulation via the CSR-1 slicing activity (Chapter 3.1). If the additional EGA 
repressors presented here, are involved in post-transcriptional regulation and if they function together 
with the identified players, or function in parallel pathways to repress EGA in the germline, remains to be 
determined. Compared to the CSR-1 pathway mutants, they exhibit more severe germline phenotypes 
suggesting additional defects to the misregulation of EGA. The identification of downstream target genes 
involved in EGA repression in CSR-1 pathway mutants has been restricted by their defects in exogenous 
RNAi, which does not allow a sufficient knockdown of target genes in the mutant backgrounds. An 
advantage of the rrr6 and rrr8 mutants to study EGA repression could be their usefulness for the 
identification of such downstream target genes via RNAi knockdown, assuming they are not involved in 
the RNAi pathway.  
Our screen for EGA activators did not yield a candidate that is directly involved in the transcriptional 
regulation of embryonic genes. Ran-2 mutant embryos initially seemed to match the expected phenotype 
of an EGA activator mutant showing embryonic development until several cell divisions and not expressing 
the EGA reporter. However, further analysis of the mutant embryos and of the phenotypes that have been 
published for ran-2-depleted embryos revealed severe defects in cell division and chromatin morphology 
suggesting that the failure to induce EGA is most likely a secondary effect. With the screen we expected 
to identify factors specifically involved in the transcriptional activation of embryonic genes, for example 
transcription factors (TFs) or chromatin regulators. Such factors have been discovered in other model 
organism to contribute to EGA. Zelda, for example, is a maternally deposited TF needed to start the 
transcription of more than a hundred embryonic genes in Drosophila melanogaster (Liang et al. 2008). 
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Our screen-setup allowed us to identify maternally or paternally deposited players in EGA initiation, by 
observing hermaphrodites of the second generation after mutagen treatment, for embryos without EGA 
reporter expression. That we did not identify such players can have several reasons. One putative reason 
is that such embryonic gene-specific TFs and chromatin regulators do not exist in C. elegans. In addition 
to screening for EGA activators, we also tried to identify TFs using other approaches, for example by 
analyzing embryonic gene promoters for TF binding motifs and depleting putative TFs associating with 
these motifs by RNAi. This approach also did not result in the identification of a TF needed to start 
embryonic transcription. A possible scenario how EGA could be controlled without embryonic gene-
specific TFs, is via a global regulation of transcription, for example by controlling Pol II complex assembly 
or controlling Pol II activity. However, players required for transcription in general could not be discovered 
in our screen, as it allowed only the discovery of maternal- or paternal-effect embryonic lethal genes, but 
not genes directly required for embryonic development, as expected for basic transcription components. 
A mechanism that globally controls the transcription in C. elegans embryos has been discovered (Guven-
Ozkan et al. 2008). Sequestration of TAF-4, a TFIID subunit, in the cytoplasm of one- and two-cell embryos 
inhibits the assembly of a functional Pol II complex and thereby transcription. The release of TAF-4 into 
the nucleus in the four-cell embryo, when EGA normally occurs, allows transcription to start. Although 
such a global regulation of transcription does not explain the specific transcription of embryonic genes, 
there are other mechanisms that could contribute to a gene-specific regulation. For example, specific 
features of embryonic genes, such as their short length as compared to all genes (Tocchini 2015), could 
contribute to their differential expression. The idea of a differential gene expression based on gene length 
follows the transcript abortion model, where during the short cell cycles of early embryos only the 
transcription of short genes is possible, whereas the transcription of longer genes is interrupted by the 
cell cycle, leading to the abortion of transcripts (Tadros and Lipshitz 2009). Another reason why we could 
not identify an EGA activator in the screen might be the redundancy of genes involved to initiate EGA. As 
EGA is very crucial for the development of the animal, redundant players or mechanisms could have 
evolved to ensure a successful embryonic development, even if one component is affected. A third reason 
for the lacking discovery of an EGA activator in our screen could be also due to screening limitations. 
However, this seems rather unlikely, because we covered the C. elegans genome more than once and our 
screen discovered several EGA repressors at the same time, which even led to the identification of several 
alleles of the same gene.  
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6 Material and Methods 
The following Material and Methods have been used for chapters 3.1 and 5.1 
Nematode culture, mutants and transgenic lines 
Animals were maintained using standard procedures and were grown at 20°C, unless stated otherwise. 
Alleles and transgenic lines are separately listed at the end of the Material and Methods chapter. 
Mutagenesis and whole-genome-sequencing (WGS) 
EMS mutagenesis was performed as previously described (Brenner 1974) using a strain carrying the EGA-
GFP reporter and a transgene to visualize P granules. Mapping of the mutants was performed as described 
in (Zuryn et al. 2010). Before WGS, each mutant was outcrossed 4-8 times to the unmutagenized parent 
strain. Genomic DNA was isolated using Gentra Puregene Tissue Kit 4 g (Qiagen). DNA libraries were made 
from 50 ng of genomic DNA using the Nextera DNA kit from Illumina. Sequencing was performed using Hi 
Seq 2000 from Illumina. 
Processing of sequence data and detection of sequence variants 
Sequence reads were aligned to the May 2008 C. elegans assembly (obtained from 
http://hgdownload.soe.ucsc.edu/goldenPath/ce6/chromosomes/) using ‘‘bwa’’ (Li and Durbin 2009); 
version 0.7.4) with default parameters, but only retaining single-hit alignments (‘‘bwa samse -n 1’’ for 
single reads and “bwa sampe -a 1000 -o 1000 -n 1” for paired end reads and selecting alignments with 
‘‘X0:i:1’’). The resulting alignments were converted to BAM format, sorted and indexed using 
‘‘samtools’’(Li et al. 2009); version 0.1.19). In order to quantify contamination by Escherichia coli, reads 
were similarly aligned to a collection of E. coli genomes (NCBI accession numbers NC_008253, NC_008563, 
NC_010468, NC_004431, NC_009801, NC_009800, NC_002655, NC_002695, NC_010498, NC_007946, 
NC_010473, NC_000913 and AC_000091), which typically resulted in less than 1% aligned reads. Potential 
PCR duplicates were identified and removed using Picard (version 1.92, 
http://broadinstitute.github.io/picard/), reducing the number of reads to 33% to 52% in single read 
samples, and to 93% in the paired-end read sample. Sequence variants were identified using GATK 
(DePristo et al. 2011) (version 2.5.2) following recommended “best practice variant detection”: Initial 
alignments were first corrected by indel realignment and base quality score recalibration, followed by SNP 
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and INDEL discovery and genotyping using “UnifiedGenotyper” for each individual strain using standard 
hard filtering parameters, resulting in a total of five to six thousand sequence variations in each strain 
compared to the reference genome. Finally, the number of high quality (score >=500) single nucleotide 
substitutions of EMS-type (G/C>A/T transitions (Drake and Baltz 1976)) not found in the parent strain 
(typically less than 1% of the total number of variants per strain) were counted in sequential windows of 
1 Mb to identify regions of increased variant density. 
Reverse transcription and quantitative PCR on dissected gonads 
RNA was isolated from 50 gonads of 1-day-old (after the L4-to-adult molt) animals using the Picopure RNA 
Isolation Kit (Arcturus). 3 independent biological replicates were collected. cDNAs were generated using 
the QuantiTect Reverse Transcription Kit (Qiagen). Real-time PCR was performed in duplicates using 
Absolute QPCR SYBR green ROX mix (AbGene) on an ABI PRISM 7700 system or an StepOnePlus system 
(both Applied Biosystems). qPCR reactions were performed as described previously (Biedermann et al. 
2009). At least one primer in each pair is specific for an exon-exon junction (see primer sequences at the 
end of the chapter). Standard curves for every primer pair were generated using a serial dilution of cDNA 
from embryos and were used to determine the amount of each transcript in the gonads. All technical 
duplicate values were first averaged, and then values for a particular transcript were normalized to the 
mean of the wild type. Error bars show the SEM for the three biological replicates.  
EGA reporter assay  
Temperature-sensitive mutants used for the EGA reporter assay were grown at 15°C. Mutant animals 
were synchronized by bleaching and put as L1 larvae on OP50 plates to 25°C until scored for EGA-GFP 
expression as adults.  
Immunostaining 
Immunostaining against SPD-2 (“969LA”, 1:800) was performed as previously described (Lin et al. 1998). 
A Zeiss Axio Imager Z1 microscope equipped with an Axiocam MRm REV 2 CCD camera was used for 
capturing pictures. Images were processed with Adobe Photoshop and Adobe Illustrator.  
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Protein Extraction and Western Blot Analysis 
Synchronized adult worms were harvested for protein extraction as described before (Biedermann et al. 
2009). Proteins were resolved by SDS-PAGE on 4-12% Bis-Tris Protein Gels (NuPAGE Novex) and 
transferred using the Trans-Blot Turbo Transfer System (BIO RAD). Membranes were blocked with 4% milk 
in PBST and incubated with the primary antibodies α-DRH-3 (Aoki et al. 2007), α-ACT-1 (MAB1501, 
Millipore), α-H2B (ab1790, Abcam) or α-PAB-1 (Scheckel et al. 2012) in blocking buffer at 4°C overnight. 
Membranes were washed three times in PBST and incubated with the secondary (HRP-conjugated) 
antibody (GE Healthcare) in blocking buffer at RT for 1 hour and again washed three times with PBST. 
Chemiluminescence was performed using Pierce ECL Western Blotting Substrate (Thermo Scientific). 
I thank Hiroaki Tabara for sharing the DRH-3 antibody. 
RNA interference 
For RNAi, animals were fed with bacteria expressing dsRNAs (targeting cdl-1 from the Ahringer library, or 
an “empty” vector as a negative control) from L1 stage. Animals were grown at 20°C and examined 65 
hours post-L1 stage for expression of the EGA reporter in germ cells. 
Selection of genes activated in the early embryo 
We downloaded microarray expression data (Baugh et al. 2003) for the samples (GSM39513-
GSM39519,GSM39543,GSM39522-GSM39526,GSM39530,GSM39531) from GEO 
(www.ncbi.nlm.nih.gov/geo/), representing the 4-cell (3x), 8-cell (4x), 15-cell (4x) and 26-cell (4x) stages. 
The data was normalized using the function justGCRMA from the Bioconductor package gcrma. We 
confirmed the high degree of consistency among the replicates and then averaged those to obtain one 
expression profile per stage. Early embryonic genes were defined as genes, which showed a change in 
expression of at least 2-fold from the 4-cell to the 8-cell or from the 8-cell to the 15-cell stages and no 
expression at the 4-cell stage (expression < 3.75). The data from the 26-cell stages was not used for 
selecting genes, as there was only little change in expression when comparing it to the 15 cell stage. 
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RNA sequencing and data analysis 
For total RNA sequencing, the samples were prepared using the ScriptSeq v2 RNA-Seq Library Preparation 
Kit (Epicentre) and then sequenced on an Illumina HiSeq 2500. The total RNA sequencing data was 
analyzed as previously described (Hendriks et al. 2014). 
The following Material and Methods have been used for chapter 3.2 
Cell-free protein synthesis and co-immunoprecipitation of proteins 
N-terminally tagged coding sequences of the respective proteins were cloned in the pCS2+ plasmid under 
the control of an SP6 promoter. Proteins were expressed from plasmids using the TNT SP6 High-Yield 
Wheat Germ Protein Expression System from Promega corresponding to manufacturer’s protocol using 
4-10 µg of plasmid in a 50 µl reaction for 2 h at 25°C. For protein binding, similar amounts of proteins were 
taken and allowed to bind for 2 h on ice in extraction buffer (50 mM HEPES, 100 mM KOAc, 5 mM MgAc, 
0.1% Triton X-100, 10% Glycerol (w/v), 20 mM β-glycerophosphate) with protease inhibitors. Antibody 
(mouse α-Myc-Tag (9B11)) was allowed to bind for 1 h at 4°C, rotating. Immunoprecipitation was 
performed using magnetic dynabeads protein G from Novex for 3 hours at 4°C rotating. Washing was done 
twice with EB (+300mM NaCl), followed by one wash in EB. Elution was performed with 1x NuPAGE LDS 
sample buffer from Invitrogen. Samples were heated for 10 min at 70°C.  Proteins were resolved by SDS-
PAGE on 4-12% Bis-Tris Protein Gels (NuPAGE Novex) and transferred using the Trans-Blot Turbo Transfer 
System (BIO RAD). Membranes were blocked with 4% milk in PBST and incubated with primary antibody 
(mouse α-Flag (M2) 1:1000 or mouse α-Myc-Tag (9B11) 1:1000) in blocking buffer at 4°C overnight. 
Membranes were washed three times in PBST and incubated with HRP-conjugated α-mouse antibody 
(1:7500) in blocking buffer at RT for 2 hours and again washed three times with PBST. Chemiluminescence 
was performed using Pierce ECL Western Blotting Substrate. 
Peptide Microarray 
The protein binding studies using peptide microarrays were performed by JPT Peptide Technologies, 
Berlin, Germany. CSR-1 peptide sequences of 18 amino acids length were synthesized and immobilized on 
the microarray slide in the following order: CSR-1 isoform B (peptides 1-96), CSR-1 MID-PIWI domain, 
amino acid residues 557-993 in duplicates (peptides 97- 144 and peptides 145-192). The C. elegans LIN-
41 FIL-NHL domain was expressed in insect cells and labeled using DyLight Microscale Antibody Labeling 
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Kit (Thermo Scientific 84536). The labeled protein was diluted to concentrations of 1 µg/mL or 0.2 µg/mL 
and incubated with the peptide microarrays. After washing and drying, the microarray slides were 
scanned using a high-resolution laser scanner to obtain fluorescence intensity profiles. Images were 
quantified and the MMC2-values of the mean pixel fluorescence were calculated for each peptide. The 
results were visualized in a heatmap diagram.  
Small RNA cloning and sequencing 
22G RNA isolation from total RNA and 22G RNA library formation were essentially performed as described 
in (Gu et al. 2011). In more detail the experiment was performed as follows: Wild type (N2) animals were 
grown on control (empty vector)/drh-3/ego-1 or lin-41 RNAi plates form L1 stage. The animals were 
harvested as young adults. Two independent biological replicates (prepared on different days) were 
prepared. RNA was isolated with TRIzol reagent. Small RNA purification was performed by loading 5 µg 
total RNA per sample on a 15% PAGE/7M Urea gel. Using a small RNA ladder as size marker, the small 
RNAs in between 20 and 25 nucleotides were cut out from the gel. The RNA was eluted in elution buffer 
(20mM Tris–HCl; 300mM NaCl; 5mM EDTA; 0.1% SDS) by smashing the gel with a plastic pestle followed 
by an incubation overnight at 4°C. The next day, the RNA was spun down using corning filter tubes and 
precipitated by adding 3 volumes of ethanol and incubating at -80°C for 1 hour. After washing the pellet 
with 80% ethanol and air drying the pellet, it was dissolved directly in 3’ linker ligation mix (1 µl 10 µM 
3’adapter oligo, 1 µl 10x T4 RNA Ligase Buffer, 2 µl 100% DMSO, 0.5 µl RNasin, 1.5 µl T4 RNA Ligase 2 
truncated K227Q, 4 µl RNA). Ligation was performed overnight at 4°C. The 5’ triphosphate of the 22G 
RNAs was removed by treating the samples with the C. elegans phosphatase PIR-1 for 30 minutes at room 
temperature. This treatment left a 5’ monophosphate which can be ligated to the 5’linker. Before 5’ linker 
ligation RT primer annealing was performed. The 5’ linker (1 µl 10 µM 5’adapter oligo, 1.5 µl 10mM ATP, 
1.5 µl T4 RNA ligase 1) was ligated at 20°C for 1 hour, followed by 37°C for 30 minutes. cDNA synthesis 
was performed with the Superscript III reverse transcriptase system (Invitrogen). To determine optimal 
cycle conditions for library amplification, pilot PCRs with increasing numbers of cycles (12-24) were 
performed. Large scale PCRs with the determined cycle number were loaded on a polyacrylamide gel and 
the amplified library was excised from the gel. The elution was performed as previously described and the 
DNA was precipitated with 3 volumes of ethanol and 1/10 the volume of sodium acetate overnight. The 
samples were sequenced on an Illumina HiSeq 2500.  
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Small RNA cloning and sequencing from CSR-1 complexes 
FLAG::CSR-1 animals were grown on control (empty vector) or lin-41 RNAi plates from L1 stage. Worms 
were harvested as young adults (replicate 1) or adult worms (replicate 2). Protein extraction was 
performed as described before (Biedermann et al. 2009). For the IPs, 11 mg protein were used for 
replicate 1 and 15 mg protein for replicate 2. IPs were performed using anti-FLAG M2 magnetic beads 
(Sigma) for 3 hours at 4°C rotating. After washing, the elution from beads was done with 125 µl elution 
buffer (50mM Tris; 5mM EDTA; 10mM DTT; 1% SDS) at 37°C for 15 minutes. For RNA extraction, 100 µl of 
the eluate were used. The remaining 25 µl were used for western blot analysis. RNA extraction was 
performed with the Picopure RNA Isolation Kit (Arcturus). Small RNA purification and library formation 
were done as previously described.  
Processing of the small RNA sequencing data 
The 3’ adaptor (TGGAATTCTCGGGTGCCAAGG) was removed from the reads using the function 
preprocessReads from within the R package QuasR (version1.12.0, default parameters). Mapping of the 
short fragments to the C. elegans genome (ce10) was performed using bowtie (Langmead et al. 2009). We 
performed two runs of alignments, one allowing only for uniquely mapping reads (UM) and one allowing 
for unique, as well as multi mappers (MM). The commands used to perform the  
alignments were qAlign(“samples.txt”, “BSgenome.Celegans.UCSC.ce10”) and qAlign(“samples.txt”, 
“BSgenome.Celegans:UCSC.ce10”,  maxHits=100), respectively. In the case of a multi mapping read, one 
alignment was selected randomly. We used the MM alignments to quantify the expression of broad 
annotation categories (e.g. rRNA, tRNA, snRNA) and the UM alignments to quantify at the single locus 
level. For each annotated feature two copies were created, one sense and one antisense, by flipping the 
respective strand. The parts of the genes covered directly by the used RNAi constructs were excluded 
from the quantification of the respective genes. Read counting was then performed using the command 
qCount (proj,exons,orientation="same"). Quantification of the broad annotation categories was 
performed by assigning each read hierarchically to the annotation classes in the following order: 
RNAiConstruct, rRNA, tRNA, snRNA, snoRNA, miRNA, 21U-RNA, ncRNA, coding_transcript (using the 
function qCount).  
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Total RNA sequencing  
The total RNA samples are identical to those that we used for small RNA cloning, see details above. For 
total RNA sequencing, the samples were prepared using ScriptSeq v2 RNA-Seq Library Preparation Kit 
(Epicentre) and then sequenced on an Illumina HiSeq 2500.  
Processing of the RNA-sequencing data 
All the RNA-seq data were mapped to the C. elegans genome (ce10) with the R package QuasR (version 
1.12.0) (Gaidatzis et al. 2015) using the included spliced alignment algorithm SpliceMap (Au et al. 2010). 
The command used to perform the alignments was "proj <- qAlign("samples.txt", 
"BSgenome.Celegans.UCSC.ce10", splicedAlignment=TRUE)". Gene expression was quantified by counting 
the number of reads that started within any of the exons belonging to a particular gene (WormBase, 
WS220). The command used to create the count table was qCount(proj,exons,orientation="same"). To 
compensate for differences in the read depths of the various libraries, we divided each sample by the 
total number of reads and multiplied by the average library size. Log2 expression levels were calculated 
after adding a pseudocount of 8 (y=log2(x+8). This was done to minimize the large differences in 
expression that would otherwise be caused by genes with small numbers of counts. 
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Alleles and transgenic lines used in this study 
CGC or Ciosk lab 
number 
Genotype 
1284 
 
rrrSi199[Pvet-4::NLS:gfp:gfp::vet-4 3’UTR; unc-119(+)] (II);  
rrrSi198[Pvet-4::NLS:gfp:gfp::vet-4 3’UTR; unc-119(+)] (IV) 
1270 
rrrSi199 (II); rrrSi198 (IV); zuIs252[nmy-2::PGL-1::RFP, unc-119(ed3)]; glo-1 
(zu391) (X) 
1350 drh-3(rrr2) (I)/hT2 (I;III); rrrSi199 (II); rrrSi198 (IV); glo-1(zu391) (X) 
1431 drh-3(rrr5) (I)/hT2 (I;III); rrrSi199 (II); rrrSi198 (IV); zuIs252; glo-1(zu391) (X) 
1600 ego-1(rrr9) (I)/hT2 (I;III); rrrSi199 (II); rrrSi198 (IV); zuIs252; glo-1(zu391) (X) 
JK3025 gld-1(q485) (I)/hT2 (I;III) 
1180 lin-41(rrr3)/unc-29(e1072), lin-11(h1281) (I); rrrSi199 (II); rrrSi198 (IV) 
1534 eri-1(mg366) (IV); rrrSi199 (II) 
1651 prg-1(tm872) (I); rrrSi199 (II) 
1617 mut-2(ne3370) (I); rrrSi199 (II) 
1616 mut-7(ne4255) (III); rrrSi199 (II) 
1610 drh-3(fj52) (I)/hT2 (I;III); rrrSi199 (II) 
1618 avr-14(ad1302) drh-3(tm1217) (I)/hT2 (I;III) ;rrrSi199 (II) 
1596 csr-1(tm892) (IV)/DnT1 (IV;V); rrrSi199 (II) 
WM191 
MAGO12: sago-2(tm894) ppw-1(tm914) ppw-2(tm110) F55A12.1(tm2686) 
R06C7.1(tm1414) I; Y49F6.1(tm1127) ZK1248.7(tm1113) F58G1.1(tm1019) II; 
C16C10.3(tm1200) K12B6.1(tm1195) III; T22H9.3(tm1186) V; 
R04A9.2(tm1116) X 
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CGC or Ciosk lab 
number 
Genotype 
1646 bqSi142[pBN20(unc-119(+) Pemr-1::emr-1::mCherry;)] (II) 
1634 drh-3(rrr5) (I)/hT2 (I;III); bqSi142 (II); rrrSi198 (IV) 
1718 
drh-3(rrr5) (I)/hT2 (I;III); rrrSi318[Pvet-4::mCherry:h2b::tbb-2 3’UTR; unc-
119(+)] (IV) 
1689 csr-1(tm892) (IV); Pcsr-1::FLAG-CSR-1(DDH)::csr-1 3’UTR (II) 
1755 csr-1(tm892) (IV)/DnT1 (IV;V); Pcsr-1::FLAG-CSR-1(AAA)::csr-1 3’UTR (II) 
1897 
drh-3(rrr2) (I)/hT2 (I;III); rrrSi321 [phsp-16.41::FLAG-GFP-LIN-41::lin-41 full-
length 3’UTR, unc-119(+)] (IV) 
1777 lin-41(rrr3) (I) /hT2 (I;III); GFP::CSR-1(CRISPR) (IV) 
1689 csr-1(tm892) (IV); Pcsr-1::FLAG-CSR-1::csr-1 3’UTR (II) 
1591 rrr6/mIn1 (II); rrrSi199 (II); rrrSi198 (IV); zuIs252; glo-1(zu391) (X) 
1184 ran-2(rrr7) (III)/hT2 (I;III); rrrSi199 (II); rrrSi198 (IV); zuIs252; glo-1(zu391) (X) 
1528 usp-48(rrr8) (I)/hT2 (I;III); rrrSi199 (II); rrrSi198 (IV); zuIs252; glo-1(zu391) (X) 
 
I thank Craig Mello for sharing several CSR-1 strains, including the CSR-1 slicer mutant, the endogenously 
GFP-tagged CSR-1 strain and the FLAG-tagged CSR-1 strain. 
I thank Peter Askjaer for providing the EMR-1::mCherry strain. 
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Real-time quantitative PCR primer sequences 
Primer Sequence 
act-1 FW CTATGTTCCAGCCATCCTTCTTGG 
act-1 RV TGATCTTGATCTTCATGGTTGATGG 
tbb-2 FW GCTCATTCTCGGTTGTACCA 
tbb-2 RV TGGTGAGGGATACAAGATGG 
vet-4 FW AAGGATTTCACTGCTTGCTC 
vet-4 RV CGTCGTTTTCGATTTCTCCG 
vet-6 FW GTGCGAGACAAGAATGTAATCC 
vet-6 RV TTCTTGAACTCTTGGAACACAG 
pes-10 FW GCGATGATTTCATGATTTCCTG 
pes-10 RV AATTTCGTAGTCAATCTGCTCC 
hlh-1 FW ACGATTATGTGACTTCCTCTC 
hlh-1 RV GATGATCTCTATCGTCGTCC 
unc-120 FW GGGTATTATGAAGAAGGCATTCG 
unc-120 RV TGCATATGTGTAGACATGACCA 
end-1 FW GGGCAATACTTTGTTCAATCG 
end-1 RV GGATACTGTTGTGAGTAGCA 
end-3 FW GCCTATTAATGACCTCCAGC 
end-3 RV CCCGTCAATTGGTATCTCTG 
pha-4 FW CCAGAATTTCCTGAACAACAC 
pha-4 RV GTTGGTGGAGCTGTAAAGAG 
elt-1 FW ACAATTCTCAATTCAGCACG 
elt-1 RV GTTGCAGAGGTAGTTTCCTG 
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